,Close,Open,High,Low,Volume,tweet
2021-01-01,826.5999755859375,822.7999877929688,828.9500122070312,820.6500244140625,2474916.0,
2021-01-04,832.25,831.0,837.2999877929688,826.5499877929688,3487801.0,
2021-01-05,827.25,832.25,843.75,825.2999877929688,4559213.0,
2021-01-06,824.7999877929688,829.0,834.4000244140625,815.25,3318460.0,
2021-01-07,826.5499877929688,830.0,830.4500122070312,818.0,2879675.0,
2021-01-08,838.7000122070312,830.7000122070312,846.2000122070312,827.4000244140625,5072916.0,
2021-01-11,856.8499755859375,839.0,860.0,832.75,5332109.0,
2021-01-12,843.1500244140625,860.0,864.5999755859375,841.0,4338010.0,
2021-01-13,841.7000122070312,847.3499755859375,852.0,832.5,3596529.0,
2021-01-14,840.9000244140625,841.7000122070312,847.5499877929688,829.0,3652930.0,
2021-01-15,823.7000122070312,839.0,844.9000244140625,821.0,3137877.0,
2021-01-18,801.75,822.0,826.6500244140625,796.2000122070312,3742440.0,
2021-01-19,822.4500122070312,802.5,825.4000244140625,802.5,3791378.0,
2021-01-20,832.7999877929688,822.5,834.9000244140625,822.2999877929688,3056546.0,
2021-01-21,812.75,835.0,839.2999877929688,809.0,3326213.0,
2021-01-22,808.2999877929688,815.7999877929688,822.5,798.25,3883231.0,
2021-01-25,836.7999877929688,813.0,857.0,808.25,10704200.0,
2021-01-27,842.5,839.9000244140625,856.4500122070312,825.2000122070312,7410174.0,
2021-01-28,841.9000244140625,835.5,848.8499755859375,825.7000122070312,4489853.0,
2021-01-29,825.9000244140625,847.9500122070312,850.8499755859375,820.75,7185812.0,
2021-02-01,806.4000244140625,815.0,831.0,779.9500122070312,13856367.0,
2021-02-02,821.5999755859375,807.0,826.3499755859375,801.5,8486828.0,
2021-02-03,849.25,826.0,878.9000244140625,824.2000122070312,15674616.0,
2021-02-04,834.4500122070312,847.5499877929688,856.5,832.5999755859375,4639606.0,
2021-02-05,847.7000122070312,839.5999755859375,854.9000244140625,830.5,7381183.0,
2021-02-08,847.25,852.0,859.25,841.0499877929688,4244906.0,
2021-02-09,841.75,848.0,856.8499755859375,839.0,4200281.0,
2021-02-10,863.4000244140625,847.5999755859375,867.0,841.0,5665209.0,
2021-02-11,859.7999877929688,868.0,874.9000244140625,856.0,5347864.0,
2021-02-12,848.5499877929688,859.0,864.3499755859375,845.5,2473012.0,
2021-02-15,844.2999877929688,850.0999755859375,856.5999755859375,842.0,2531913.0,
2021-02-16,848.3499755859375,850.0,852.25,841.25,2808115.0,
2021-02-17,835.7000122070312,849.4500122070312,854.7000122070312,833.0,2539649.0,
2021-02-18,825.4500122070312,835.0,843.4500122070312,822.5,4114251.0,
2021-02-19,807.3499755859375,823.7999877929688,825.4500122070312,799.0,3834443.0,
2021-02-22,792.4500122070312,811.4000244140625,817.5,786.0499877929688,4090429.0,
2021-02-23,790.9500122070312,795.0,803.1500244140625,788.4000244140625,3264477.0,
2021-02-24,789.0499877929688,794.0,798.0999755859375,776.25,1587082.0,
2021-02-25,809.1500244140625,795.0,814.0,790.4500122070312,5478169.0,
2021-02-26,787.0499877929688,805.0,820.0,780.0,7549015.0,
2021-03-01,789.7999877929688,795.0,800.5,782.0,2748271.0,
2021-03-02,811.7999877929688,792.5999755859375,815.0,790.7999877929688,4275166.0,
2021-03-03,812.5,817.9500122070312,818.1500244140625,807.5999755859375,3265559.0,
2021-03-04,806.75,807.4000244140625,818.0,803.7000122070312,3640996.0,
2021-03-05,805.1500244140625,806.5,812.0,800.25,3832170.0,
2021-03-08,809.25,807.9500122070312,819.0,806.2000122070312,2915298.0,
2021-03-09,797.0,812.5999755859375,816.7000122070312,792.0999755859375,2783825.0,
2021-03-10,812.4000244140625,806.0,814.75,801.0,2512573.0,
2021-03-12,805.9500122070312,816.5,818.7000122070312,802.0,2082799.0,
2021-03-15,805.5,807.9000244140625,808.9000244140625,790.0,2651062.0,
2021-03-16,792.2999877929688,805.0999755859375,808.5,787.0,3671229.0,
2021-03-17,772.1500244140625,794.7999877929688,794.7999877929688,770.0,3246092.0,
2021-03-18,755.1500244140625,776.0,778.4500122070312,750.8499755859375,2894624.0,
2021-03-19,760.6500244140625,751.0,767.25,738.0999755859375,5262000.0,
2021-03-22,772.8499755859375,762.0,784.5999755859375,758.7000122070312,3563266.0,
2021-03-23,776.0999755859375,775.0,779.4000244140625,768.4000244140625,2118532.0,
2021-03-24,792.9500122070312,777.7999877929688,798.7000122070312,772.6500244140625,6904173.0,
2021-03-25,787.25,796.9000244140625,802.2999877929688,783.2999877929688,5292130.0,
2021-03-26,787.4500122070312,791.0,799.0,781.25,2934548.0,
2021-03-28,,,,,,"#HTWknd | @HT_Ed talks to Cipla's Yusuf Hamied about #vaccines, pricing and the future of patents. And looks back on the time when Hamied faced off with Big Pharma amid the #AIDS epidemic, and won.   https://t.co/sKRvpny7z8,#HTWknd | @HT_Ed talks to Cipla's Yusuf Hamied about #vaccines, pricing and the future of patents. And looks back on the time when Hamied faced off with Big Pharma amid the #AIDS epidemic, and won.   https://t.co/sKRvpnPIqG"
2021-03-30,812.2000122070312,790.25,815.9000244140625,790.25,4453933.0,"Nifty Pharma joins the bull bandwagon, index surges over 2%; Torrent Pharma, Cipla, Divis Lab most active  https://t.co/NWY2Qaly4q #Nifty #niftypharma #StockMarket #StocksToWatch #stocks #TorrentPharma #cipla #DIVISLAB"
2021-03-31,815.0999755859375,811.0,823.9500122070312,805.0,3075406.0,"Cipla joins peers in #investing in #digital #health firm  https://t.co/kR6LUHVRyM,Buy Cipla, target price Rs 966:  ICICI Securities  #ETMarkets #DailyRecos #StockPicks #DailyPicks  https://t.co/SuY4XmUy3W"
2021-04-01,818.2999877929688,819.5,824.0,811.5999755859375,1910949.0,"#remdesivir ‡™á‡™®‡´ç‚Äç‡™ú‡´á‡™ï‡´ç‡™∂‡™®‡™®‡™æ ‡™â‡™§‡´ç‡™™‡™æ‡™¶‡™ï‡´ã ‡™ú‡´á‡™Æ ‡™ï‡´á, Hetero Drugs Ltd., Cipla Ltd., Mylan Laboratories Ltd., Cadila Healthcare Ltd., Dr. Reddy's Lab. Ltd., Jubilant Lifescience Ltd. ‡™¶‡´ç‡™µ‡™æ‡™∞‡™æ ‡™ï‡™∞‡™µ‡™æ‡™Æ‡™æ‡™Ç ‡™Ü‡™µ‡´á ‡™õ‡´á. #coronavirus #CoronavirusPandemic #ZEE24Kalak    https://t.co/fR7kEJWEH9,Telangana: IICT and Cipla distribute one lakh face masks in six months  https://t.co/czSVusZtsY,#CIPLA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?  https://t.co/gojNArRhTQ  https://t.co/c6IGG3DF2V,My friend @Rakeshdun helped his employer raised several crores of such FDs from Dehradun in early and mid 90s. Later did same for Alpic (reverse of CIPLA). But as I said, an aggressive Kamath changed the game forever- ABV regime played an ally &amp; that was the start of #IndiaStory"
2021-04-02,,,,,,"Lupin, Alkem face 'higher risk' of U.S. FDA inspections, Cipla least at risk: Jefferies  Read more:  https://t.co/p9ltcDdQfY  https://t.co/0aD9P5EcBu"
2021-04-05,819.75,825.0,827.0,806.0999755859375,2920638.0,"‡§ú‡•ã ‡§´‡§º‡§æ‡§∞‡•ç‡§Æ‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä inj Remdesivir ‡§¨‡§®‡§æ ‡§∞‡§π‡•Ä ‡§π‡•à‡§Ç ‡§â‡§®‡§∏‡•á ‡§∂‡§ø‡§µ‡§∞‡§æ‡§ú ‡§ú‡•Ä ‡§Ü‡§™ ‡§§‡§§‡•ç‡§ï‡§æ‡§≤ ‡§ö‡§∞‡•ç‡§ö‡§æ ‡§ï‡§∞‡•á‡§Ç‡•§‡§Ü‡§ú ‡§â‡§ú‡•ç‡§ú‡•à‡§® ‡§Æ‡•á‡§Ç ‡§ï‡§ø‡§∏‡•Ä ‡§ï‡•á ‡§™‡§æ‡§∏ ‡§Ø‡§π ‡§®‡§π‡•Ä‡§Ç ‡§π‡•à‡•§‡§á‡§Ç‡§¶‡•å‡§∞ ‡§Æ‡•á‡§Ç ‡§≠‡•Ä ‡§ï‡§Æ‡•Ä ‡§¶‡•á‡§ñ‡•Ä ‡§ú‡§æ ‡§∞‡§π‡•Ä ‡§π‡•à‡•§ Manufacturers  1 Zydus Cadilla  2 Cipla Mumbai  3 Hetro Hyderabad  4 Sun Pharma Mumbai  5 Dr Reddy Hyderabad  6 Mylon Bangalore,@Cipla_Global Thanks for prompt response. I have DMed the number. Your help will be greatly appreciated.,üö®ANNOUNCEMENTüö®  We're delighted to announce Cipla's @maxirich_in as our Official Immunity Partner for #IPL2021 üíô  Together with Maxirich, we aim to safeguard the health and wellness of our players and support staff ü§ùüèΩ  Read More:  https://t.co/7QplCcxELI  #YehHaiNayiDilli  https://t.co/foNRwwBH9R,#OPINION | India‚Äôs pharma industry is reimagining itself. This is not just borne out of the necessities brought forth by the pandemic, but is a blueprint to thrive and to succeed in this new world.  https://t.co/TzrHbyR4Cr | ‚úçÔ∏è: SAMINA HAMIED, @Cipla_Global  https://t.co/1kO17Mva2P"
2021-04-06,836.1500244140625,824.0,845.0,821.8499755859375,4569120.0,"@kumarmanish9 @MadhishParikh @ShambhaviRai9 @mojilo_manas Prayers for speedy recovery. Great thanks to @Cipla_Global for prompt response as well üôè,No words would be enough to thank the @Cipla_Global team in Mumbai and Patna for the help and support they providedüôè.,Nifty Pharma climbs over 1% amid progress in Covid-19 vaccination drive; Cadila, Cipla, Sun Pharma, Dr Reddy's top bulls  https://t.co/eZuPse3Vd5 #nifty #niftypharma #sensex #stock #StocksInNews #stocks #StockMarket #cadila #cipla #SunPharma #drreddy #COVID„Éº19,#CIPLA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?  https://t.co/nxDJkWs0fx  https://t.co/aTdlEWKCnH,Archives | In the early 2000s, Yusuf Hamied, the chairman of Cipla, decided to sell a three-drug ‚Äúcocktail‚Äù therapy for HIV to patients in Africa for just $1 a day. Until then, the treatment cost around $1,000 a year.   @VidyaKrishnan and @MandakiniGahlot:  https://t.co/Gc4CT6Ol0p  https://t.co/REyNv13akl,@PhDSulemanKhoja @Cipla_Global @BJP4UP @ZydusUniverse thanks."
2021-04-07,840.8499755859375,836.1500244140625,844.9000244140625,830.25,2404472.0,"MoS Chemical @mansukhmandviya on #Remdesivir: These 7 manufacturers - #Mylan, Hetero, #JubiliantLife, #Cipla, #DRL, #ZydusCadila &amp; #SunPharma - have monthly production capacity of 31.60 lk vials.  Letters have been despatched to these drugmakers to ramp up production (Agencies)  https://t.co/vMomcISe9f,@Cipla_Global please check DM. Urgent üôè"
2021-04-08,842.0,843.0,850.4500122070312,838.4000244140625,2459821.0,"Buy Cipla, target price Rs 966:  ICICI Securities  #ETMarkets #DailyRecos #StockPicks #DailyPicks  https://t.co/PNNLbuKw4J,#SharekhanResearch #Q4FY21 Pharma Preview, API focused companies to drive the growth, India focused cos with high chronic presence to grow at healthy pace; Pref picks Aurobindo, Cipla, Divis, Laurus Labs, Dr Reddys, Lupin, Sanofi India, Abbott India, Strides Pharma,Gland Pharma,#CIPLA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?  https://t.co/gDJTHdspmk  https://t.co/Y4bcUhrsux"
2021-04-09,883.0499877929688,840.9000244140625,892.2999877929688,836.6500244140625,11189432.0,"Can #SerumInstituteIndia and #BharatBiotech partner with other manufacturing facilities to ramp up #Covid19 #Vaccine production faster, asks @tanvishukla   @grumpeoldman, Former Global General Counsel Of Cipla &amp; Glenmark responds!  https://t.co/jMgIOgeJoV,*9.4 cr vaccine doses administered in India so far; several vaccination centres across the country run out of doses  *Cipla &amp; Cadila ramp up production of #COVID drug #Remdesivir: #CNBCTV18Exclusive  *‚Çπ remains under pressure; touches an 8-month low  #Headlines @Parikshitl  https://t.co/mYzgVlfYAV,#MarketAtClose | ICICI Bank &amp; HDFC Bank contribute nearly 80% to Nifty Bank fall  Demand rise for remdesivir lifts pharma stocks such as Cadila, Cipla &amp; Jubilant  https://t.co/zEFHSW2F2p,#MarketAtClose | Nifty Banks slips 335 pts to 32,448 while midcap index rises 43 pts to 24,506  Cipla, Sun Pharma, HUL, Tech Mahindra &amp; Wipro top index gainers  Reliance, ICICI Bank &amp; HDFC Bank drag nifty by 44 points,Closing Bell: Indices end lower; Sensex drops 150 pts; Nifty below 14,850 levels. Gainers: Cipla (+5%), Sun Pharma (+3%). Losers: Bajaj Finance (-3%), UPL (-2%).  https://t.co/Az3zJ49USZ #Nifty #Sensex #StockMarket,Host of pharma &amp; diagnostic companies are buzzing in trade. Industry sources indicate Cipla, Cadila gain on the back of a ramp-up in production of #Remdesivir drug amid a supply shortage. Metropolis, Thyrocare, Dr Lal gain on higher COVID-19 testing. @ekta_batra  https://t.co/ga8R4dvCgd,Unlike with drugs, freeing up patents will not make it any easier to manufacture vaccines for COVID-19, says Cipla‚Äôs Yusuf Hamied. @ljishnu writes:   https://t.co/Yv0uSMd1PF,#Topstory: Catch up with the all the latest piping hot #CSuite movements of the #Q4 2020-2021 here with a single click!  @FabindiaNews @Capgemini @KPMG @PiramalGroup @TitanCompanyLtd @ArcelorMittal @Cipla_Global @MahindraRise @delhivery @whitehatjunior     https://t.co/aLooWGCgZx,See #CIPLA.  Record high.  https://t.co/sRZEmTsTOW,Industry sources tell us that pharma companies such as Cipla &amp; Cadila are ramping up production of drug #Remdesivir. Cos had slowed down production in mid Dec &amp; Jan due to lower number of #COVID19 cases.   However, demand for the drug has risen substantially &amp; suddenly since Jan  https://t.co/WjbVJAPlxy,Cipla very good chart structure...what recovery from recent lows  https://t.co/vkbLkQStAU,Announcing @heenakanal, Vice President &amp; Head Corporate Communications @Cipla_Global, as our Juror for #KaleidoAwards. She is a specialist in PR, Analyst &amp; Advisor Relation, Crisis Communication &amp; more. Join us for the Felicitation Ceremony.  Know more :  https://t.co/GESlqYA3S7  https://t.co/Xs5evolofQ,#cipla #covid19 ‡§ï‡•á ‡§â‡§™‡§ö‡§æ‡§∞ ‡§Æ‡•á‡§Ç ‡§ï‡§æ‡§Æ ‡§Æ‡•á‡§Ç ‡§Ü‡§®‡•á ‡§µ‡§æ‡§≤‡•Ä ‡§°‡•ç‡§∞‡§ó #Rendemsivir ‡§°‡§æ‡§Ø‡§∞‡•á‡§ï‡•ç‡§ü ‡§Æ‡§∞‡•Ä‡§ú‡•ã ‡§ï‡•ã ‡§™‡§Ç‡§π‡•Å‡§ö‡§æ ‡§∞‡§π‡•Ä ‡§π‡•à ‡§ú‡•ç‡§Ø‡§æ‡§¶‡§æ ‡§ú‡§æ‡§®‡§ï‡§æ‡§∞‡•Ä ‡§ï‡•á ‡§≤‡§ø‡§è ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ ‡§™‡§∞ ‡§ï‡§æ‡§≤ ‡§ï‡§∞‡•á  https://t.co/FwxFx5qt47"
2021-04-10,,,,,,"@Cipla_Global Thank you :) sharing it with needy people,One friend in Pune requires remdesvir urgently and its not available there. Can anyone help if they know where it can be procured there? @Cipla_Global @heteroofficial @drreddys"
2021-04-11,,,,,,"@PhDSulemanKhoja @CMOMaharashtra @Cipla_Global @AUThackeray @Maha_MEDD @PIBMumbai @mybmc @MumbaiPolice @kiranshaw @supriyasahuias @MantralayaRoom Dear Suleman, we are unable to provide support as we do not manufacture this drug. We wish speedy recovery to the patient.,‡§∂‡§æ‡§∏‡§® ‡§¶‡•ç‡§µ‡§æ‡§∞‡§æ ‡§î‡§∑‡§ß‡§ø ‡§®‡§ø‡§∞‡•ç‡§Æ‡§æ‡§§‡§æ ‡§ï‡§Æ‡•ç‡§™‡§®‡§ø‡§Ø‡•ã‡§Ç Cipla, Dr. Reddy, SunPharma ‡§è‡§µ‡§Ç Mylan ‡§ï‡•á ‡§Æ‡§æ‡§ß‡•ç‡§Ø‡§Æ ‡§∏‡•á Remdesivir ‡§ï‡•Ä ‡§™‡§∞‡•ç‡§Ø‡§æ‡§™‡•ç‡§§ ‡§Æ‡§æ‡§§‡•ç‡§∞‡§æ ‡§Æ‡•á‡§Ç ‡§Ü‡§™‡•Ç‡§∞‡•ç‡§§‡§ø ‡§∏‡•Å‡§®‡§ø‡§∂‡•ç‡§ö‡§ø‡§§ ‡§ï‡§∞‡§®‡•á ‡§π‡•á‡§§‡•Å ‡§Ü‡§µ‡§∂‡•ç‡§Ø‡§ï ‡§ï‡§æ‡§∞‡•ç‡§Ø‡§µ‡§æ‡§π‡•Ä ‡§ï‡•Ä ‡§ó‡§Ø‡•Ä ‡§π‡•à: ‡§Æ‡•Å‡§ñ‡•ç‡§Ø‡§Æ‡§Ç‡§§‡•ç‡§∞‡•Ä ‡§∂‡•ç‡§∞‡•Ä ‡§∂‡§ø‡§µ‡§∞‡§æ‡§ú ‡§∏‡§ø‡§Ç‡§π ‡§ö‡•å‡§π‡§æ‡§®,. @ZydusHospitals , @Cipla_Global , @mylan, @Hetero @JubilantLifesciences and @DrReddy Laboratories have production capacities for #Remdesivir,@soni_bharadwaja @healthminmp @ChouhanShivraj @VishvasSarang We have already requested M/s Cipla and M/s Biocon to send more vials to MP. The problem will ease out soon. Thanks for raising the issue. üòä,@Cipla_Global @RichPurelyRich Hi, tried reaching out on the helpline but cannot get through and constantly on wait. Please guide.,@varunkrish I saw some forward with a Cipla toll-free number saying call to get it. Perhaps some search on those lines will yield some results."
2021-04-12,902.4000244140624,890.0,940.0,879.1500244140625,30141861.0,"Mr Pathik Shah -9769727771 Mr Vaibhav Khairnar -9272372811  Mr Bose 9347341757 bose@heterohealthcare.com Mr Vijay thorat 9820748050 Mr Shastri 9820528432 Mr Shenoy ‚Äì 93231 43036  Hetero International &amp; Cipla Mr Pankaj Thakur : +91 8433946055 Mr Bhavesh Shah : +91 9821044912,For Remdesivir injection             Cipla customer care 8657311088 info.availability@cipla.com Hetero Helpline : 18001034696; whatsapp : 9320985814; covifor@heterohealthcare.com  Hetero Healthcare (Mumbai) Priorities Mr Yogesh Patil -9322067716 yogeshpatil@heterohealthcare.com,Thank you Cipla team for sharing ‚ÄúCaring for Life- The Cipla Story since 1935‚Äù. Great to witness Cipla‚Äôs legacy and pioneering work in making quality medicines accessible and affordable for the masses.  @Cipla_Global*  https://t.co/JnJVqPQ9Ma,@whitespeaking FYI @vikasbansi1 @Cipla_Global @sukanyaiyer2 ji,#MarketAtClose | Pharma names like Dr Reddy‚Äôs, Cipla &amp; Divi‚Äôs gain as COVID cases rise  https://t.co/dzUjcWZ260,Closing Bell: Markets closed more than 3% down; Sensex sheds over 1700 pts; Nifty below 14,350-mark. Gainers: Dr Reddy (+7%), Cipla (+2%). Losers: Tata Motors (-9%), Adani Ports, IndusInd Bank (-8%).   https://t.co/VdXh9niTjL #Nifty #Sensex #stocks #StockMarket,@VIPINKSURELIA @Cipla_Global @AUThackeray @priyankac19 Wishing her speedy recovery,#MarketsWithETNOW | #Cipla hits life high, volume at 9x the 20-day average  https://t.co/f3wnbVhWXQ,SEC likely to give a decision on Emergency Approval to Sputnik V vaccine. @NithyaBala84, Director, Sanford Bernstein says the approval will be a positive for Dr Reddy's Lab. Tells @ekta_batra @latha_venkatesh that Sun Pharma &amp; Cipla are among their top recommendations  https://t.co/SQihjBN5NO,Nifty Pharma shrugs off bearish markets tone, index climbs 1%; Cipla, Dr Reddy's lift the performance  https://t.co/Fo5w9CSH6y #Nifty #NiftyPharma #sensex #StockMarket #stocksinnews #stocks #cipla #DrReddy,@sanchak74 And Cipla, the one of the biggest manufacturers of ivermectin in India, has focused its attention on remdesivir instead due to the potential for much higher profits.,@MNCDFbombay @Cipla_Global @mybmc @CiplaFoundation @CMOMaharashtra @MantralayaRoom This Needs immediate concern,Good catch cipla,#MarketsWithETNOW | #Pharma and #diagnostic stocks in focus. Fresh longs seen in the following stocks.  @Cipla_Global @lalpathlabs  https://t.co/E9yQ0r2UQu,#CIPLA marks 52-week high. #BULLISH  https://t.co/7ihOR1AjaD  https://t.co/F93Q0E7WuT,Opening Bell: Market opens lower; Sensex plunges over 800 pts; Nifty below 14,600 levels. Gainers: Cipla, Infosys (+2%). Losers: IndusInd Bank (-6%), Bajaj Finance, SBI (-4%).   https://t.co/VdXh9niTjL #Nifty #Sensex #StockMarket #Stocks,#StocksInNews | #CIPLA, #DRL, #CADILA ‡§´‡•ã‡§ï‡§∏ ‡§Æ‡•á‡§Ç, ‡§∏‡§∞‡§ï‡§æ‡§∞ ‡§®‡•á #Remdesivir ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§î‡§∞ API ‡§™‡§∞ ‡§∞‡•ã‡§ï ‡§≤‡§ó‡§æ‡§à  @AEHarshada  https://t.co/g1LWDbwT3A"
2021-04-13,885.2000122070312,921.9500122070312,932.5999755859376,878.2999877929688,11667200.0,"Pharmaceutical company #Cipla on Tuesday said it has scaled up the production of #remdesivir by 2 times from the last wave of the #pandemic.  Photo: IANS (File)  https://t.co/H8Jbissbdq,Cipla doubles remdesivir production to meet 'unprecedented' demand  https://t.co/oThcKm19tc  https://t.co/cuFZ3l9SIX,Cipla Doubles Remdesivir Production To Meet ‚ÄòUnprecedented‚Äô Demand   #cipla #covidvaccine #covid19 #latesthealthnews    https://t.co/6Pe5RNlw44,Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet ‚Äúunprecedented demand‚Äù as India battles a massive second wave of infections, the drugmaker said on Tuesday.   https://t.co/seDfx1fhMM,Just two months ago, Cipla had projected falling demand for #remdesivir in India as #coronavirus infections were on a steady decline.    https://t.co/ZoXbs74FaO,@anvaya_anand BMC commissioner told @CNBCTV18News  today they have bought 2 lakh vials from Mylan &amp; supplied to some hospitals. Exports banned &amp; 7 companies told to double production, but one expert said will take 20 days. Cipla more hopeful  https://t.co/1pByXCuTCn,Read more -  https://t.co/bWaDc69aDr  Cipla Doubles Remdesivir Production In India For ""Unprecedented"" Demand  #Remdesivir #COVID19  https://t.co/Ye2NIePUlQ,India's Cipla has doubled the production of #COVID19 medication #Remdesivir to help meet ""unprecedented demand"" as the country battles a massive second wave of infections, the drugmaker said.  https://t.co/eJQQRINNWq,India's Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet ""unprecedented demand"" as the country battles a massive second wave of infections, the drugmaker said on Tuesday  https://t.co/o5AzmMTSQB,Cipla doubles remdesivir production to meet 'unprecedented' demand  https://t.co/ve0kUz4Asm  https://t.co/N6jDkWh7rr,Cipla doubles remdesivir production to meet 'unprecedented' demand  https://t.co/cYSqYtv7Wg by @sachinr27,#Covid19SecondWave: India‚Äôs Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet ‚Äúunprecedented demand‚Äù   @Cipla_Global #VaccineUpdates #Covid_19    https://t.co/zcLGdbF9qC,Cipla Doubles Remdesivir Production In India For ""Unprecedented"" Demand  https://t.co/lfZ8YXRpcF  https://t.co/kuufbG31kX,India's Cipla Ltd has doubled production of Covid-19 medication Remdesivir to help meet ""unprecedented demand"" as the country battles a massive second wave of infections, the drugmaker said    https://t.co/f937oYhjmi,Cipla doubles remdesivir production to meet 'unprecedented' demand  https://t.co/ylKc0xuAYZ,'Unprecedented demand': Cipla doubles Remdesivir output as Covid-19 cases surge  https://t.co/wE1BjImJ5o,COVID-19 drug manufacturers Cipla and Zydus Cadila scale up Remdesvir‚Äôs production     https://t.co/b3vGJbFrmv,Cipla tells CNBC-TV18, the company has scaled up production of Remdesvir by 2x from last wave of pandemic &amp; ramping up further via its network to meet demand  https://t.co/AufZNCzRxx,Cipla to CNBC-TV18  On Remdesvir,  - Scaled up production of Remdesvir 2X from last wave - Now ramped up capacities even more - Unprecedented demand for Remdesvir   Also,  - Facing shortage of Tocilizumab given spike in cases - Working to ensure availability  #COVID19,Opening Bell: Market opens on a positive note; Sensex rallies over 140 pts; Nifty above 14,300 levels. Gainers: Cipla, Powergrid (+2%). Losers: TCS, Adani Ports (-2%).   https://t.co/REyT59AbOP #Nifty #Sensex #StockMarket #Stocks,#MarketsWithETNOW | Nifty gains 75 points led by Cipla &amp; Dr Reddy‚Äôs; Nifty Bank gains over 200 points as all stocks gain  https://t.co/EuCzq0kbJj,#CNBCTV18Market | Power grid, Cipla &amp; M&amp;M top #Nifty gainers in opening trade  https://t.co/RWLXtRpiSw,#MarketsWithETNOW | Nifty gains 75 points led by Cipla &amp; Dr Reddy‚Äôs; Nifty Bank gains over 200 points as all stocks gain  https://t.co/eY5HFnFDGg,#CIPLA marks 52-week high. #BULLISH  https://t.co/2djEjCaRbQ  https://t.co/LBRi9gSd0n,#TradeSpotlight ‚ö°Ô∏è @kshanand finds out what experts have to say about Dr Reddy‚Äôs, Cipla and Infosys.  #StockMarket #StockstoWatch   https://t.co/69cKynDdIJ"
2021-04-14,,,,,,"‡§Æ‡•ã‡§†‡•Ä ‡§¨‡§æ‡§§‡§Æ‡•Ä! ‡§Ü‡§§‡§æ ‡§∞‡•á‡§Æ‡§°‡•á‡§∏‡§ø‡§µ‡•ç‡§π‡•Ä‡§∞‡§ö‡•Ä ‡§ï‡§Æ‡§§‡§∞‡§§‡§æ ‡§≠‡§æ‡§∏‡§£‡§æ‡§∞ ‡§®‡§æ‡§π‡•Ä, 4 ‡§Æ‡•ã‡§†‡•ç‡§Ø‡§æ ‡§î‡§∑‡§ß ‡§ï‡§Ç‡§™‡§®‡•ç‡§Ø‡§æ‡§Ç‡§ö‡§æ ‡§¶‡§æ‡§µ‡§æ #cipla #Coronadrugremdesivir #covidsecondwave #sunpharmacompany  https://t.co/d2i6PLzRQ7,@SARahma26661919 @rajsinghrahul0 @Cipla_Global @akashtomarips @srinivasiyc üëç,@SARahma26661919 @rajsinghrahul0 @Cipla_Global @akashtomarips @srinivasiyc Ok let me try,@rajsinghrahul0 @SARahma26661919 @Cipla_Global @akashtomarips @srinivasiyc Pl give any contact no,@_EkBharatiya_ @sredits @om_speaks @DarshanNPopat @Dev_Fadnavis @TMCaTweetAway @CMOfficeAssam @sandhyafernez @sukanyaiyer2 @Cipla_Global @rajeshtope11 @ImThanekar @DigiThane @Thane_R_Police @KiritSomaiya @ShivsenaComms @UdhavThackeray @Krunal_Goda,All those people who are struggling to get #Remdesivir please try these numbers and email floated by CIPLA, one of the pharma companies that make this drug.   I haven't approached these lines myself. You may tag me giving your feedback though.  https://t.co/xquk3CE361,@ad77a9adb499423 Please contact @Cipla_Global üôè,@Cipla_Global @HemantSorenJMM,Mumbai-based pharma major @Cipla_Global has doubled up #Remdesivir production as nation-wide shortage continues.   #RemdesivirShortage | #COVID19  https://t.co/vT239puUxE,Scaled up remdesivir production two-fold: Cipla #ETIndustryNews  https://t.co/q0KchJLJ5X,@BasuTiwari94 @shalabhmani @CovidIndiaSeva Please check @Cipla_Global üôè,Cipla To Scale Up Remdesivir Production Two-Fold To Meet ‚ÄòUnprecedented Demand‚Äô For The Drug   https://t.co/8rgtFzuG2D,India is largest manufacturer of remdesivir with Hetero being largest of all @ 10.5 lakh vials pm. Besides Herero, Sun,Zydus,Cipla,Kamla,DrReddy,Mylan all manufacture it in huge nos- a patient would need 5 injections -surely enough capacities  exists in the system-don‚Äôt choke it!,Indian firms, including Hetero Drugs, Zydus Cadila and Cipla, produce #Remdesivir injections under a licensing agreement with Gilead.  Read today's #MintPrimer by @shreejayjnu -   https://t.co/5nBe9jd1g1  https://t.co/VfyC1ZVx9r,#Cipla: Have raised #Remdesivir production two-fold  @Cipla_Global  https://t.co/Xe5SxBfZpK,Cipla doubles remdesivir production to meet 'unprecedented' demand  https://t.co/PWiywx8aQV  https://t.co/uFm8zgxSej"
2021-04-15,914.2000122070312,898.7999877929688,925.4000244140624,883.9000244140625,13218002.0,"The demand has gone through the roof. Zydus Cadila, Dr Reddy‚Äôs, Sun Pharma, Cipla, all say they are increasing prodn but inputs from the supply chain is different. Business Insider called the Cipla #Helpline but there was nothing but a pre-recorded message...  https://t.co/v3tfKuQAQa,Cipla set up helplines 86573 11088 | 022 6282 0886 for information regarding availability of critical Cipla products like REMDESIVIR injection. You can also email them your requirement - info.availability@cipla.com and their team will assist you. RT Plzüôè #COVID19 #Covid19India  https://t.co/haRf9EEikz,However, when Business Insider called the Cipla helpline ‚Äî not once but twice ‚Äî there was nothing but a pre-recorded message that played on a loop for over five minutes, before the call was abruptly ended.  #COVIDSecondWave  https://t.co/ASTZjuVCAH,Closing Bell: Market ends lower; Sensex slumps over 250 pts; Nifty below 14,600 levels. Gainers: TCS, Wipro, Cipla (+3%). Losers: Grasim, Eicher Motor (-3%).   https://t.co/iyED2QrxO8 #Nifty #Sensex #StockMarket #Stocks,@sandhyafernez @Cipla_Global @ajaynadkarni Is this only for #Mumbai and #Bangalore?,@KunalNavander @SlightlyEpic_ Do we have a relevant resource for Mumbai from Cipla? I've also written to the mail id.,Buy Cipla, target price Rs 975:  ICICI Direct  #ETMarkets #DailyRecos #StockPicks #DailyPicks  https://t.co/Wd9leFVYfD,Thusday's Bull: Nifty Pharma soars 2% despite fragile markets; Cipla, Cadila, Sun Pharma drive the index  https://t.co/pXa4a9tCXB #Nifty #sensex #StocksToBuy #stocks #StockMarket #Cipla #cadila #SunPharma,This is #CIPLA. Seen by some analysts as a major beneficiary of #Remdesivir surging demand. #COVID @CNBC_Awaaz @CNBCBajar  @tapariachandan  https://t.co/hw61Sd32s4,Remdesivir ‡§¨‡§®‡§æ‡§®‡•á ‡§µ‡§æ‡§≤‡•Ä cipla ‡§ï‡•á ‡§á‡§® ‡§´‡•ã‡§® ‡§®‡§Ç‡§¨‡§∞‡•ã‡§Ç ‡§∏‡•á ‡§∂‡§æ‡§Ø‡§¶ ‡§ï‡•ã‡§à ‡§Æ‡§¶‡§¶ ‡§π‡•ã ‡§ú‡§æ‡§è. Thank you Cipla  https://t.co/Y4xE9qzXGk"
2021-04-16,938.0499877929688,919.75,944.25,910.9000244140624,13746268.0,"@stranger2029682 Cetirizine tablet from Cipla !!,ùóúùó†ùó£ùó¢ùó•ùóßùóîùó°ùóß  8657311088 this is toll free number of CIPLA, manufacturer of Remdesivir.  Those in need can reach out directly &amp; the company is providing the injections directly to Hospital without any dealer etc.  Save the number, Share it with people around you in need.,#‡§Ö‡§¨‡•ç‡§¶‡•Å‡§≤ ‡§∏‡§ø‡§∞‡•ç‡§´ ‡§™‡§Ç‡§ö‡§∞ ‡§π‡•Ä ‡§®‡§π‡•Ä ‡§¨‡§®‡§æ‡§§‡§æ ‡§≠‡§ï‡•ç‡§§‡•ã, ‡§ñ‡•ç‡§µ‡§æ‡§ú‡§æ #‡§Ö‡§¨‡•ç‡§¶‡•Å‡§≤ ‡§π‡§Æ‡•Ä‡§¶ ‡§ï‡•Ä #Cipla ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§ï‡§æ ‡§∏‡§¨‡§∏‡•á ‡§ï‡§æ‡§∞‡§ó‡§∞ #‡§∞‡•á‡§Æ‡§°‡•á‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§≠‡•Ä ‡§¨‡§®‡§æ‡§§‡•Ä ‡§π‡•à‡•§,‡§Ö‡§Ç‡§ß‡§≠‡§ï‡•ç‡§§‡•ã‡§Ç ‡§Ö‡§¨‡•ç‡§¶‡•Å‡§≤ ‡§ï‡•á‡§µ‡§≤ ‡§™‡§Ç‡§ö‡§∞ ‡§π‡•Ä ‡§®‡§π‡•Ä‡§Ç ‡§¨‡§®‡§æ‡§§‡§æ ‡§π‡•à,  ‡§Ü‡§ú #COVID19 ‡§ï‡§æ ‡§∏‡§æ‡§Æ‡§®‡§æ ‡§ï‡§∞‡§®‡•á ‡§Æ‡•á‡§Ç ‡§ú‡§ø‡§∏ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® '‡§∞‡•á‡§Æ‡•Ä‡§°‡§ø‡§∏‡§µ‡•Ä‡§∞' ‡§ï‡§æ ‡§â‡§™‡§Ø‡•ã‡§ó ‡§π‡•ã ‡§∞‡§π‡§æ ‡§π‡•à, ‡§µ‡§π ‡§ñ‡•ç‡§µ‡§æ‡§ú‡§æ ‡§Ö‡§¨‡•ç‡§¶‡•Å‡§≤ ‡§π‡§Æ‡•Ä‡§¶ ‡§ï‡•Ä ‡§ï‡§Ç‡§™‡§®‡•Ä #CIPLA ‡§Æ‡•á ‡§¨‡§®‡§§‡§æ ‡§π‡•à !!!,@prafull_0609 @jigneshmevani80 @amdavadipraja @MadhishParikh @Cipla_Global @Mukeshias @drrajivguptaias @svphospital @AmdavadAMC @DrOmMachraIAS @MoHFW_INDIA @MoHFW_GUJARAT Please check with #Tocilizumab distributers in #Indore: BAKLIWAL BROTHERS: 0731-4084694 2704820 Dhruvi Pharma: 0731-2577876 / 9303277446 D.N.SANGHVI &amp; SONS: 0731-2306175 2306176 GOPI MEDICAL STORES: 9226360694 VACCINE HUB: 0731-4009366  #IndoreFightsCorona #COVID19,@prafull_0609 @jigneshmevani80 @amdavadipraja @MadhishParikh @Cipla_Global @Mukeshias @drrajivguptaias @svphospital @AmdavadAMC @DrOmMachraIAS @MoHFW_INDIA @MoHFW_GUJARAT I will share it soon!,@jigneshmevani80 @amdavadipraja @MadhishParikh @Cipla_Global Hello @jigneshmevani80 , please check with this #Tocilizumab distributers list of #Gujarat.  https://t.co/JGeyUrixAX,Anybody looking for Remdisivir injections, please directly contact Cipla hotline. There is no shortage.  Do not go to blackmarketers or spurious dealers. #covid19 #Remdesivir #remdesivirShortage  https://t.co/1ale4sCBLq,@amdavadipraja @AmitHPanchal @MadhishParikh @Cipla_Global Ok. Let me try with other sources.,@AmitHPanchal @MadhishParikh @Cipla_Global @amdavadipraja try this and update me,@jigneshmevani80 @MadhishParikh Please connect with @Cipla_Global for #Tocilizumab and Call them on 8657311088 or email them on info.availability@cipla.com #Ahmedabad #COVID19,Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ.,.@drreddys @Cipla_Global @SunPharma_Live @MoHFW_INDIA @NIPERHyd @jamia_hamdard @ICTMumbai1933   More *Remdesivir* production please..........   Pharma unit you can save people.   #COVIDSecondWave,Cipla, Zydus and Hetero are producing Remedesivir. They were directed to ramp up production to 78 mill/month. With ban on exports of Remdesivir, where the hell is it going? Why can Govt initiate Epidemic Act and Disaster Mgmt Act and take charge of all the production of cos?,@Atulmaharaj @namratawrites @PhDSulemanKhoja @kumarmanish9 @MadhishParikh @Cipla_Global @hydcitypolice @MoHFW_INDIA @drharshvardhan @HydSMENews @SunPharma_Live Check @LAKSHMIALAPATI3 handle for more updates on #Remedisivir,@Atulmaharaj @namratawrites @PhDSulemanKhoja @kumarmanish9 @MadhishParikh @Cipla_Global @hydcitypolice @MoHFW_INDIA @drharshvardhan @HydSMENews @SunPharma_Live Check @LAKSHMIALAPATI3 handle for more updates on #RemiTweetforSweet,@Atulmaharaj @namratawrites @PhDSulemanKhoja @kumarmanish9 @MadhishParikh @Cipla_Global @hydcitypolice @MoHFW_INDIA @drharshvardhan @HydSMENews @SunPharma_Live Dr. Reddy‚Äôs has launched a website to track the availability of Remdesivir on real-time basis across India... pls share it with people and assist people who are in need of this injection...  https://t.co/MMgj7WMKrA,@abbas_nighat 8657311088 cipla 24hrs helpline number. I have checked, it's correct..  you can contact them to provide Ramidisivar injection..They will send it, directly to the patient.,@Atulmaharaj @namratawrites @PhDSulemanKhoja @kumarmanish9 @MadhishParikh @Cipla_Global @hydcitypolice @MoHFW_INDIA @drharshvardhan @HydSMENews @SunPharma_Live Hi. I am able to see u have tagged me, but not the message u want me to retweet. Pls share the tweet,Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ.,This is a call for help!! Urgently need #remedisivir injections for my uncle who is covid positive and is in critical condition in Agra hospital!! @narendramodi  @myogiadityanath @myogioffice @Cipla_Global @cmoagra @MantralayaRoom #Remdesivir #pardhanmantrijanaushadikendra #COVID,@Prafulshri Someone has sent me this.  Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done just now.  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ,@TajinderBagga @shalabhmani Someone has sent me this.  Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done just now.  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ,@modivanibharat @bhootnath Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done just now.  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ,@KapilMishra_IND @shalabhmani @dmgtb @CeoNoida @noida_authority @112UttarPradesh Someone has sent me this.  Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done just now.  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ,@PhDSulemanKhoja @MadhishParikh @Cipla_Global @hydcitypolice @MoHFW_INDIA @drharshvardhan @HydSMENews @SunPharma_Live @urban_lens see if you can connect.,Please Share /Retweet  Cipla ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡§æ ‡§ü‡•ã‡§≤ ‡§´‡•ç‡§∞‡•Ä ‡§®‡§Ç‡§¨‡§∞ 8657311088 (24 ‡§ò‡§Ç‡§ü‡•á ‡§â‡§™‡§≤‡§¨‡•ç‡§ß) ‡§π‡•à.  PS: Verification done just now.  ‡§ú‡§ø‡§® ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®  ‡§ï‡•Ä ‡§ú‡§∞‡•Ç‡§∞‡§§ ‡§π‡•à,‡§â‡§®‡•ç‡§π‡•á‡§Ç ‡§∏‡•Ä‡§ß‡•á ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§Ø‡§æ ‡§ú‡§æ‡§è‡§ó‡§æ‡•§‡§á‡§∏‡§Æ‡•á‡§Ç ‡§¨‡•Ä‡§ö ‡§Æ‡•á‡§Ç ‡§ï‡•ã‡§à ‡§°‡•Ä‡§≤‡§∞ / ‡§µ‡§ø‡§§‡§∞‡§ï  / ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§®‡§π‡•Ä‡§Ç ‡§π‡•ã‡§ó‡§æ."
2021-04-17,,,,,,"Meds like #Remedisivir and #Tocilizumab have run out in the national capital. There are patients in hospitals in urgent need. Urging @Cipla_Global to push their stock to the distributors.,@kkmaurya @Cipla_Global Please share the contact number.,Drug companies like Cadila Healthcare, Dr Reddy's Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of COVID-19.   https://t.co/iPqjlFnpcJ,Prices of the Remdesivir injection have been VOLUNTARILY reduced by pharma companies,said the National Pharmaceutical Pricing Authority.Cipla's branded product will now cost Rs 3,000/vial instead of Rs 4,000,Cadila Healthcare to charge Rs 899 instead of Rs 2,800 @tragicosmicomic,@aminali83 @srinivasiyc @SaniaAhmad1111 @Cipla_Global @ShaleenMitra üôè,Bruke Pharma has Requested @OfficeofUT to Give Permission .Last 4 Days they have got no communication from CM office and u trying to bluff and Create Wrong Narrative ! U Let Cipla Supply 11000 #Remedisivir to Chattisgarh from Maharashtra from last 2 days ! What ur say on this?,@aminali83 @srinivasiyc @varunchoudhary2 @dilipkpandey @KapilChopra72 @durgeshjhaTOI @CMODelhi @drharshvardhan .@SaniaAhmad1111 @Cipla_Global @ShaleenMitra,@Swaty_Here @AmitHPanchal @MadhishParikh @zubinashara @Cipla_Global,Cipla has published its list of distributors across India for Remdesvir.  Remdesvir:  https://t.co/GA4DSDcWhs  Tocilizumab:  https://t.co/fY9EXOt07z,@milanjoshidx Cipla has published its list of distributors across India for Remdesvir.  Remdesvir:  https://t.co/GA4DSDcWhs  Tocilizumab:  https://t.co/fY9EXOt07z,@milanjoshidx Just check the Cipla list, I just posted, and see the near by distributor. Try contact them pls.,Cipla helpline number: 86573 11088 022-6282 0886  Cipla has started a helpline to share information about the availability of critical Cipla products like Cipremi (Remdesivir) and Ciplenza (Favipiravir).,.@Cipla_Global Tocilzumab injection is out of stock every where in India. Kindly take necessary steps urgently.,‡§∞‡•á‡§Æ‡§ø‡§°‡•á‡§∏‡§ø‡§µ‡•Ä‡§∞ ‡§¨‡§®‡§æ‡§®‡•á ‡§µ‡§æ‡§≤‡•Ä ‡§ï‡§Æ‡•ç‡§™‡§®‡•Ä CIPLA  ‡§ï‡•á ‡§¨‡§æ‡§∞‡•á ‡§Æ‡•á‡§Ç ‡§ú‡•ã ‡§Æ‡§æ‡§®‡§∏‡§ø‡§ï ‡§∞‡•ã‡§ó‡•Ä  ‡§ï‡•Å‡§õ ‡§®‡§π‡•Ä‡§Ç ‡§ú‡§æ‡§®‡§§‡•á ‡§µ‡•ã ‡§ï‡§Æ‡§≤ ‡§ï‡§æ ‡§´‡•Ç‡§≤ ‡§∏‡•Ç‡§Ç‡§ò ‡§ï‡§∞ ‡§Ö‡§™‡§®‡§æ ‡§ï‡§æ‡§Æ ‡§ö‡§≤‡§æ‡§è‡•§ #StayHome,Urgently in need of Remdisiver for a patient in rainbow hospital, SP Verma Road, Patna. We have already tried Cipla etc helplines and they have ran out of medicine.  Contact 9820589348. @dm_patna  @officecmbihar @mangalpandeybjp,Supplier lists for essential #COVID management drugs by cipla across India. #COVID19India,‡§ó‡§æ‡§Ç‡§ß‡•Ä ‡§ú‡•Ä ‡§ï‡•á ‡§™‡§∞‡§Æ ‡§Ö‡§®‡•Å‡§Ø‡§æ‡§Ø‡•Ä ‡§Ö‡§¨‡•ç‡§¶‡•Å‡§≤ ‡§π‡§æ‡§Æ‡§ø‡§¶ ‡§®‡•á 1935 ‡§è‡§ï ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§¨‡§®‡§æ‡§à CIPLA, ‡§â‡§®‡§ï‡•á ‡§¨‡•á‡§ü‡•á ‡§Ø‡•Å‡§∏‡•Ç‡§´ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡•á ‡§ì‡§®‡§∞ ‡§π‡•à‡§Ç‡•§ ‡§ú‡•Ä‡§µ‡§® ‡§∞‡§ï‡•ç‡§∑‡§ï ‡§∞‡•á‡§Æ‡§ø‡§°‡•á‡§∏‡§ø‡§µ‡•Ä‡§∞ ‡§¨‡§®‡§æ‡§®‡•á ‡§™‡§∞ ‡§ú‡•ã‡§∞ ‡§≤‡§ó‡§æ‡§è ‡§π‡•Å‡§è ‡§π‡•à‡§Ç‡•§‡§Ø‡•á ‡§¶‡•á‡§∂ ‡§ó‡§æ‡§Ç‡§ß‡•Ä ‡§ï‡§æ ‡§π‡•à ‡§î‡§∞ ‡§ó‡§æ‡§Ç‡§ß‡•Ä‡§µ‡§æ‡§¶‡•Ä ‡§π‡•Ä ‡§á‡§∏‡•á ‡§¨‡§ö‡§æ‡§è‡§Ç‡§ó‡•á‡•§  https://t.co/fBZOjd08KX,#Remedisivir #CIPLA  https://t.co/Uz48rHpe4d"
2021-04-18,,,,,,"‡§∞‡•á‡§Æ‡•á‡§°‡§ø‡§∏‡§ø‡§µ‡§∞ ‡§ï‡§Ç‡§™‡§®‡§ø‡§Ø‡•ã‡§Ç ‡§®‡•á ‡§ú‡§æ‡§∞‡•Ä ‡§ï‡§ø‡§è ‡§®‡§Ç‡§¨‡§∞,‡§∏‡•Ä‡§ß‡•á ‡§Ü‡§∞‡•ç‡§°‡§∞ ‡§ï‡§∞‡•á‡§Ç @ via- Social media   Cipla-8657311088, Hetero-040-40473535, Jubiliant-9819857718, Mylan-7829980066,‡§∞‡•á‡§Æ‡•á‡§°‡§ø‡§∏‡§ø‡§µ‡§∞ ‡§ï‡§Ç‡§™‡§®‡§ø‡§Ø‡•ã‡§Ç ‡§®‡•á ‡§ú‡§æ‡§∞‡•Ä ‡§ï‡§ø‡§è ‡§®‡§Ç‡§¨‡§∞,‡§∏‡•Ä‡§ß‡•á ‡§Ü‡§∞‡•ç‡§°‡§∞ ‡§ï‡§∞‡•á‡§Ç @ via- Social media   Cipla-8657311088, Hetero-040-40473535, Jubiliant-9819857718, Mylan-7829980066,@tohidivity @Cipla_Global @dilipkpandey We are trying from our end. This medicine is not available anywhere as of now. #SOSIYC,#Cipla chairman Dr Yusuf Hamied has a solution to counter the shortage of #Remedisivir, writes Anushka Jagtiani  #COVIDEmergency #COVID19India #VaccinationDrive   https://t.co/0hAa7CuJYy,@ShrutiSiag @AUThackeray @CMOMaharashtra @OfficeofUT @SonuSood @Cipla_Global @mybmc We request you to dial K/W Ward control room at 022-26208388, 8928443687 for further guidance.,@sahilshah0801 @Cipla_Global @CiplaFoundation @kumarmanish9 @MadhishParikh üëçüèºhope you get it,@KushaKapila Can @Cipla_Global pls help out directly????,@kumarmanish9 @sahilshah0801 @Cipla_Global @CiplaFoundation @aditiraval @MadhishParikh @amandeep14 Ok let me give a try,@sahilshah0801 @Cipla_Global @CiplaFoundation @aditiraval @MadhishParikh @amandeep14 @ipskabra sir, can you help and guide on this.,#Remedisivir manufacturing companies initiated on GOI request by decreasing the price in this #COVIDEmergency   Zydus Cadila- from Rs 2,800 to Rs 899.¬† Dr Reddy- Rs 5400 to Rs 2700 Sygene- Rs 3950 to Rs 2450 Cipla- Rs 4000 to Rs 3000 Hetero - RS 5400 to Rs 3490  And many more..  https://t.co/quvUHDBTs2"
2021-04-19,946.2999877929688,945.25,955.0,924.0,17805574.0,"Hey all, one of my friend‚Äôs father in ICU on ventilator, requires Cipla's #Tocilizumab urgently. Any leads? Tried many sources but no availability.  @MadhishParikh @aditiraval @kumarmanish9 @AmitHPanchal @RjDhvanit @CollectorAhd #Ahmedabad #Tocilizumab400  #Gujarat #COVID19  https://t.co/GQoqpAmewt,#GrowwDigest: Daily Highlights | 19 Apr 21 - (1/6)  #Sensex: 47,949.42 üîΩ1.81%  #Nifty: 14,359.45 üîΩ1.77%   Top Gainers (Nifty 50): Dr Reddy, Britannia, Cipla, Wipro &amp; Infosys   Top Losers (Nifty 50): Adani Ports, Power Grid, ONGC, Hero Moto &amp; Bajaj Finserv,#Live from #KaleidoAwards'21 Jury Meet :  Here's, @heenakanal, Vice President &amp; Head Corporate Communications, @Cipla_Global. Looks like we've got the winner.   Finalists to be announced Tomorrow! Register here for Awards Night on 30th April :  https://t.co/oAqJ9bXxgl  #Awards  https://t.co/NPmpbRLFbp,#MarketAtClose | Dr Reddy‚Äôs, Cipla, Britannia, Infosys &amp; Wipro Close Higher In A Weak Session  HDFC Bank Recovers 3% From Lows To Close With Minor Cuts Post Earnings  Pharma &amp; Hospitals Continue To Move Higher On Rising COVID Cases  https://t.co/MtJfnzRLQi,Closing Bell: Market ends lower; Sensex drops over 850 pts; Nifty below 14,350 levels. Gainers: Dr Reddy (+2%), Cipla (+1%). Losers: Adani Ports, Power Grid (-4%).   https://t.co/0jxrLitDGU #Nifty #Sensex #StockMarket #stocks,‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡•Ä ‡§ì‡§∞ ‡§∏‡•á ‡§ú‡§º‡§∞‡•Ç‡§∞‡§§‡§Æ‡§Ç‡§¶ ‡§Æ‡§∞‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§¨‡§ø‡§®‡§æ ‡§ï‡§ø‡§∏‡•Ä ‡§°‡•Ä‡§≤‡§∞/ ‡§µ‡§ø‡§§‡§∞‡§ï ‡§ï‡•á ‡§∏‡•Ä‡§ß‡§æ ‡§Ö‡§∏‡•ç‡§™‡§§‡§æ‡§≤ ‡§§‡§ï ‡§™‡§π‡•Å‡§Ç‡§ö‡§æ‡§®‡•á ‡§ï‡•Ä ‡§Ö‡§®‡•Ç‡§†‡•Ä ‡§™‡§π‡§≤‡•§   Cipla : 8657311088 Hetero: 18001034696; whatsapp : 9320985814 Mr Vinayagam ‚Äì 99943 99990 Mr Dipendra ‚Äì 75079 46363 Mr Apoorv ‚Äì 96626 12576,#StocksInNews | @Cipla_Global hits all-time high, gains over 16% MTD    #StocksToWatch #MarketsWithETNOW #pharma  https://t.co/VrGUm2gJ5M,Nifty Pharma Index edges higher despite fragile markets; DR Reddy's, Cipla lift the performance  https://t.co/qr2P0nM1zh #nifty #niftypharma #StockMarket #StocksToBuy #stocks #drreddy #cipla #sensex #nse #bse,@vinitsingh1928 @yaserjilani @CMOfficeUP @Cipla_Global @dm_ghaziabad @Gen_VKSingh Can you please share the contact details of the Patient.,Sharekhan Research brings #market calls that you can ACT on, daily!   Listen to today‚Äôs 3R Research ACTIONABLE UPDATES:  https://t.co/spRywcyxcM   Today, we cover: #HDFCBANK #Cipla   Don‚Äôt forget to subscribe!   #Sensex #Nifty #StockMarket #SharekhanKar  https://t.co/hKBC204ylp,@SagrikaKissu Have sent some information to Vikram. Hope something clicks. Still checking. Best option is cipla helpline.,#CIPLA marks 52-week high. #BULLISH  https://t.co/dyxjo3Hexw  https://t.co/B8FCD8e7Sd,#SharekhanFNA #SharekhanResearch retains buy on #Cipla (PT Rs 1100); Promising growth outlook of high single digit to low double digit for IPM for FY2022 to drive India bizz, Ramp up in gAlbuterol strong product pipeline in respiratory &amp; complex generics to fuel US sales growth,This man @actormanojjoshi needs Remidisivir injection badly.   Remember Moron, The owner of the Company CIPLA, that manufactures the life saving medicine #REMDESIVIR is Yusuf Hameed.  https://t.co/NQu4Y72ZK8,‡§∞‡•á‡§Æ‡•á‡§°‡§ø‡§∏‡§ø‡§µ‡§∞ ‡§ï‡§Ç‡§™‡§®‡§ø‡§Ø‡•ã‡§Ç ‡§®‡•á ‡§ú‡§æ‡§∞‡•Ä ‡§ï‡§ø‡§è ‡§®‡§Ç‡§¨‡§∞,‡§∏‡•Ä‡§ß‡•á ‡§Ü‡§∞‡•ç‡§°‡§∞ ‡§ï‡§∞‡•á‡§Ç @ via- Social media   Cipla-8657311088, Hetero-040-40473535, Jubiliant-9819857718, Mylan-7829980066,This sick moron is still playing Hindu-Muslim game when scores are dying across India. I‚Äôm sure he would not accept #Remdesevir by Cipla, whose owner is Muslim and #PfizerVaccine which was invented by another Muslim Uƒüur ≈ûahi!  https://t.co/96YAy6G9O3"
2021-04-20,949.2999877929688,965.0999755859376,966.3499755859376,941.0999755859376,10205616.0,"@Roflindian @dakuwithchaku @PBnrg @AskThePankazzzz Even I called today  Cipla helpline / contacts...for an hour for someone but no response ...ufff...,@amrendrajha1 @its__prakash @Cipla_Global @Viral54512223 @vishal_pratap06 @KDMCOfficial @TMCaTweetAway @mybmcHealthDept @OmprakashU25 @Brand_K_K @shalabhmani @yogitabhayana @SonuSood .  @amrendrajha1 ji, our team will try our best to arrange asap.   #BJYMCares,@tweetntrolll @ZydusHospitals @LilavatiHRC @HospitalsApollo It‚Äôs difficult to get. Stock is not available and n idea about black market .. harsh reality.. globally demand is high and supply is zero - only @Cipla_Global can confirm,Nifty Pharma tops 310 pts despite volatile markets; Cadila, Cipla hit new record high; Dr Reddy's, Aurobindo drive too  https://t.co/e2h9Kf82yC #Nifty  #niftypharma #sensex #StockMarket #StocksToWatch #stocks #cipla #cadila #drreddy #auropharma,Chhattisgarh govt considering legal action against Cipla for failing to meet Remdesivir supply requirements.  #Chhattisgarh #Remdesivir #COVID19 #Cipla   https://t.co/l2k2klsKV7,Buy Cipla, target price Rs 1025:  ICICI Securities  #ETMarkets #DailyRecos #StockPicks #DailyPicks  https://t.co/m9SJNpvxZA,Pharma rally now shifting to second rung counters such as #wockhardt #RPGLife after frontline counters such as #CIPLA, #CADILA trade near record highs. @CNBC_Awaaz @CNBCBajar,According to Singh Deo, the Indian pharma major had reneged on the contract signed on April 3 to supply #Remdesivir injections to the state  @dilasha reports  #Chhattisgarh #RemdesivirInjections #Cipla #Coronavirus   https://t.co/OXlMAka0iL,Zero availability of Tocilizumab in Mumbai and Pune. Its life saving drug thats not made in India, it's imported by @Cipla_Global  Please direct Cipla to procure more drugs @OfficeofUT @rajeshtope11 @mybmc,In the domestic market, growth is expected to come from Covid-related drugs  Ram Prasad Sahu reports   #CoronavirusPandemic #USStocks #Pharmacompanies #Cipla   https://t.co/2HyaKGylyE,@active8mysoul Yes. I saw. Updated daily, I think. Right now they‚Äôre out of stock. There‚Äôs a Cipla helpline number I have shared too.,2. Cipla is currently giving Remedesivir injections directly to the hospital where a patient has been admitted in order to avoid the black marketing of the medicines. Cipla websites ‚Äì  https://t.co/eG4AEJhcF1 , email at ‚Äì¬† info.availability@cipla.com, helpline no. ‚Äì 8657311088,@rohanduaTOI @BJYM @IYC @cmohry @mlkhattar @CharuPragya @JJPofficial @BJP4Haryana @DC_Gurugram @police_haryana @anilvijminister @Rao_InderjitS @DeependerSHooda Cipla is currently giving Remedesivir injections directly to the hospital where a patient has been admitted in order to avoid the black marketing of the medicines. Cipla websites ‚Äì  https://t.co/eG4AEJhcF1 , email at ‚Äì¬† info.availability@cipla.com, helpline no. ‚Äì 8657311088"
2021-04-21,,,,,,"The Breakup of the quantities of vials assured is as follows   1) Hetero Labs 3000 vials   2) Cipla 1500 vials  3) Sun Pharma 320  4) Mylan 500  5) Dr Reddy‚Äôs lab 1000  6) Zyrus 432   Jubilant will also provide the quantity.  #COVID19Vaccine  #BombayHC #Nagpur,@torres_bluru And if ppl get cured will you l write your wealth to them? This is a time for vaccinations. Read the comments made right bow by I think cipla md that not one person with both doses of vaccines died,Patient-Mr Nikhil Tiwari Hospital Medanta Indore(ICU) Require-Tocilizumab 400mg/20ml (Company Cipla) They wanted 2 purchase d medicine but no idea where 2 acquire. Kin-Akhil Tiwari Contact-9479725658/9129530138 @rohit_chahal @CharuPragya @The_NehaJoshi @arvinddamani #BJYMCares,@amandeep14 @indiacares_2020 @Cipla_Global @CiplaFoundation @ipskabra @Teensthack @kumarmanish9 Hi   Please contact the number below. Also kindly DM us the details of the patient, contact number and location.  Stay safe Team Biocon  https://t.co/NCaKDGzAgG,@PCITweets @AbbinTheepura @Cipla_Global @CiplaFoundation @CiplaArchives @scribe_prashant @SwatiMathurTOI @visually_kei @shemin_joy @SobhanaNair @Vohra_Umang Pls DM,@jainrahul_ And there's a cipla list too,@jainrahul_ Pl contact cipla distributors. List shared,@mojilo_manas @arvindg1970 @MadhishParikh @AmitHPanchal @MoHFW_INDIA @PMOIndia @JPNadda @CMOGuj Yes high hopes from @Cipla_Global,@AnkitAgarwalOfc @rocheindia @Cipla_Global @CiplaFoundation To ensure that you get the most relevant information about our products, please visit this link and submit your request via the form  https://t.co/SP19HEPC6r  Wishing you all the very best.  Ana on behalf of the Roche Social Media team,@AnkitAgarwalOfc @rocheindia @Cipla_Global @CiplaFoundation You can review our Social Media Guidelines here:  https://t.co/mwEFlPYeON   Hence, as your comment mentions tocilizumab it has been deleted.  We hope that you understand.,@AnkitAgarwalOfc @rocheindia @Cipla_Global @CiplaFoundation Hello!  Thank you for your comment. Unfortunately, the legal requirements regarding health communication necessitates that we will delete any comment that mentions products, be it our own or another company‚Äôs.,@sushil99691847 @Iamrahulkanal @AUThackeray @ShivSena @zeeshan_iyc @Cipla_Global Hi   Please contact the number below. Also kindly DM us the details of the patient, contact number and location.  Stay safe Team Biocon Biologics  https://t.co/4UvxDIvmEs,@ManojKu56712270 @cipla Registering patient on our system. Someone from our team will contact them.,Pl help this family. @FaridabadDc @yashpalmurar Ji Pl get it looked into.  these 2 injections ACTEMRA 400 mg from Cipla pharmacies Urgently. they can buy from anyone anywhere Pan India In Faridabad/ Delhi or lucknow Ankush: 9838034567 Madan Lal :9415101437  Shweta - 9838330044"
2021-04-22,944.3499755859376,958.7999877929688,963.1500244140624,938.8499755859376,8522208.0,"‡§¨‡§ø‡§π‡§æ‡§∞ ‡§Æ‡•á‡§Ç ‡§è‡§ï-‡§è‡§ï ‡§µ‡•ç‡§Ø‡§ï‡•ç‡§§‡§ø ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§ø‡§°‡•Ä‡§∏‡•Ä‡§µ‡•Ä‡§∞ ‡§Ü‡§¶‡§ø ‡§¶‡§µ‡§æ‡§à ‡§â‡§™‡§≤‡§¨‡•ç‡§ß ‡§®‡§π‡•Ä‡§Ç ‡§π‡•Å‡§Ü ‡§§‡•ã ‡§∞‡§æ‡§ú‡•ç‡§Ø ‡§Æ‡•á‡§Ç Cipla ‡§î‡§∞ Hetero ‡§ú‡•à‡§∏‡•Ä ‡§¶‡§µ‡§æ ‡§ï‡§Ç‡§™‡§®‡§ø‡§Ø‡•ã‡§Ç ‡§ï‡•ã ‡§¨‡§Ç‡§¶ ‡§ï‡§∞‡§µ‡§æ ‡§¶‡•á‡§Ç‡§ó‡•á‡•§  ‡§â‡§®‡§ï‡§æ ‡§ë‡§´‡§ø‡§∏, ‡§∏‡•á‡§≤‡•ç‡§∏ ‡§Æ‡§æ‡§∞‡•ç‡§ï‡•á‡§ü‡§ø‡§Ç‡§ó ‡§†‡§™‡•ç‡§™ ‡§ï‡§∞‡§µ‡§æ ‡§¶‡•á‡§Ç‡§ó‡•á‡•§ ‡§Ø‡§π ‡§ï‡•ã‡§à ‡§ß‡§Æ‡§ï‡•Ä ‡§®‡§π‡•Ä‡§Ç, ‡§Æ‡•á‡§∞‡§æ ‡§ï‡§†‡•ã‡§∞ ‡§®‡§ø‡§∞‡•ç‡§£‡§Ø ‡§π‡•à‡•§ @Cipla_Global @heteroofficial  https://t.co/38kH7eFcel,@anuraggargca @PMOIndia @MoHFW_INDIA @drharshvardhan @amitabhk87 @doctorsoumya @WHO @ficci_india @PIB_India @HospitalsApollo @NITIAayog you can contact the cipla helpline number 8657311088 for your requirement against doctors prescription,Most WhatsApp groups get messages like this,for critical medicines,oxygen etc Many can be fake A friend contacted this so-called distributor of Cipla who gave him the details of an SBI account in Budaun in the name of Cipla. Cipla says it's a fake @SidharthNSingh @myogiadityanath  https://t.co/4Edz8ZK1Up,Cipla issues caution against Remdesivir scammers: Preying on the vulnerable and how you can save yourself   https://t.co/Oj8BlRke3P,@shashankrawat_1 @abvpup @rohit_chahal @DeepakPathakDU @RahulKothariBJP @Cipla_Global @SunPharma_Live @drreddys @MoHFW_INDIA @BJYM @bjym4up Kindly reach out to our karykarta of @AbvpMeerut18 .  https://t.co/wPjg4T31ED,@rohanduaTOI @BJYM @IYC @gurgaonpolice @cmohry @anilvijminister @srinivasiyc @DC_Gurugram @BloodDonorsIn @p_sahibsingh @ABVPDelhi Dr Reddy Labs is showing non availability.   Their helpline number is 1800-266-708  Cipla‚Äôs helpline no. - 8657311088   Or email - info.availability@cipla.com,#CIPLA marks 52-week high. #BULLISH  https://t.co/aCzVxFxd7M  https://t.co/CFGfNAjJxc,Deleted this tweet from yesterday. Thank you everyone from helping. This was found through CIPLA. +91 8657311088. They will give #Remdisivir to the hospital.   https://t.co/7nxtuN1p7Y #Delhi #NCR  https://t.co/2d6ug4vuxz,Bihar has been allocated 24,500 vial of Remdesivir till 30 th April.14K Cadilla,6,500 Hetero,1K Myian,2K Cipla,1KJubilant by Dept of Pharmaceuticals. Companies have been directed to dispatch as per the agreed State allocation &amp; mapping.@News18Bihar @ZeeBiharNews @ABPNews"
2021-04-23,935.5999755859376,944.3499755859376,952.8499755859376,922.75,7972589.0,"Cipla gets go-ahead to export drugs to 30 African countries  https://t.co/efF2d7iFCV #MonitorUpdates,@pratish269 @AyushPatel9910 @FirhadHakim @Cipla_Global @MamataOfficial @AITCofficial @AUThackeray @mybmc At present we do not have information for Kolkata. @AapKolkata  if you can help please try.,Huge shortage &amp; black marketing of Tocilizumab. Cipla not getting allocation of Tocilizumab from Roche Switzerland. Why isn't Indian Ambassador to Switzerland @AmbassadorMohta not taking up the issue with Roche for India specific allocation? CEO NHA @PraveenGedam   please try,@AyushPatel9910 @pratish269 @FirhadHakim @Cipla_Global @MamataOfficial @AITCofficial @AUThackeray @mybmc The request is for Kolkata.,@Anubhav_28 @tvsmotorcompany @_PVRCinemas @Wipro @Amul_Coop @CNBCTV18News @MRFWorldwide @Cipla_Global Thanks Anubhav!  Never knew that. CIPLA-&gt; Chemical Industrial &amp; Pharmaceutical Laboratories. Also... ITC -&gt; Imperial Tobacco Company of India.,@prashy74 cc @rubenmasc your cipla leads in the morning... could they help?,Cipla to manufacture lifesaving medicines for ECOWAS, Zazibona¬†regions  https://t.co/t9vbFf515J,Had a conversation with an official from Roche, extra stock of Tocilizumab from across the world is being shifted to India and Brazil.  In India, Cipla is responsible for its marketing. It is expected in 24-48 hours. Hope it reaches hospitals directly, reduces shortfall  #Covid,Cipla has issued an advisory for the public to beware of the scammers who are defrauding people on pretext of arranging Remdesivir injections  https://t.co/Oj8BlR2CFf,Comrades, a quick cough syrup review. Let me be honest: the taste of Cofsils is bakwaas! Cipla should improve the taste of this one and bring it to the level of Cofdex or Dilosyn. The old Bricarex syrup used to taste similar. As regards Grillinctus, the less said, the better."
2021-04-24,,,,,,"Police too stretched to deal with such crime,but @RBI @DasShaktikanta need to penalize @TheOfficialSBI for virtually zero KYC. How do scamsters go and open a bank account in the name of Cipla? Even after SBI was made aware of the scam, it has not blocked access to the funds"
2021-04-25,,,,,,"@nishant_879 @Amitberi @KapilMishra_IND @TajinderBagga @Cipla_Global @TeamSOSIndia Please contact to @iAkshitDahiya 9999262612  @anuraggautam07 9119000200  Area wise ABVP Delhi helpline numbers  https://t.co/kTeA33XEL7,@itsmeshambhavi @KapoorHimanshi @ggiittiikkaa @AamAadmiParty @mygovindia @Cipla_Global @PMOIndia @ManishJangidJNU @iAkshitDahiya @anuraggautam07 Please contact to @iAkshitDahiya 9999262612  @ManishJangidJNU 9024118562  Area wise ABVP Delhi helpline numbers  https://t.co/W3oIc0C845,@sagi_occ @PMCPune @PMCMCO @mohol_murlidhar @IAS_Rubal @MantralayaRoom @CovidIndiaSeva @ppcr_pune @TeamSOSIndia @Cipla_Global @SunPharma_Live @AUThackeray @CMOMaharashtra Dear Sagar Samel, Thank you very much for contacting us. Would you please be so kind to send us an email adress or phone number by which our colleagues could get in contact with you? We will make sure that you will be contacted quickly.,@toonyswabbs Cipla supplies to distributors only.,@AlishaCoelho @BeingDeeSee Not available anywhere that we know, In the meantime pls call the Cipla and biocon helplines,‚ÄúThis is what Cipla, a company founded in 1935 by Khwaja Abdul (KA) Hamied following Mahatma Gandhi‚Äôs call to make affordable drugs available to India‚Äôs poorest citizens, has been doing for years.‚Äù   https://t.co/3OzISKrDsH,On one hand communist goons trying their level best to discredit &amp; disrupt India's fight against COVID  On the other hand, we have Nationalist like Adani, Reliance, Tata, Serum, Cipla doing their level best to help India fight #COVID with Vaccines, Oxygen, Ventilators, Injections  https://t.co/MsFvdyhvNY"
2021-04-26,905.4000244140624,935.5999755859376,940.0,902.1500244140624,10255697.0,"@KaalaChasma @SimmiAhuja_ @iamsowmya18 @AryanAnurag13 @mayank_sxn @sojanjs Agreed. But this seems urgent. Can do that as back up if it works. Cipla if by luck delivers in hrs or else two three days.,#GrowwDigest: Daily Highlights | 26 Apr 21 - (1/7)  #Sensex: 48,386.51 ‚ñ≤ 1.06% #Nifty: 14,485.00 ‚ñ≤ 1.06%  üîºTop Gainers (Nifty 50): Axis Bank, ICICI Bank,UltraTech Cement, JSW Steel &amp; Grasim  üîΩTop Losers (Nifty 50): Cipla, Britannia, HCL Tech, BPCL &amp; HDFC Bank  https://t.co/ByHUky98mC,@Sengaricha @srinivasiyc @ABVPNoida @GautamGambhir @fortis_mhbs @Cipla_Global @iAkshitDahiya @anuraggautam07   Our karyakarta will contact you soon. We will make sure arrangements are made timely  https://t.co/m4JkBRePxe,‡§¶‡§ø‡§®‡§æ‡§Ç‡§ï 26.04.2021 ‡§ï‡•ã M/s Cipla Health Care ‡§¶‡•ç‡§µ‡§æ‡§∞‡§æ 600 ‡§Ø‡•Å‡§®‡§ø‡§ü Govt ‡§ï‡•ã M/s Mylan ‡§¶‡•ç‡§µ‡§æ‡§∞‡§æ 10000 Govt ‡§ï‡•ã ‡§è‡§µ‡§Ç M/s Sun Pharma ‡§¶‡•ç‡§µ‡§æ‡§∞‡§æ 2040 ‡§π‡•á‡§≤‡•Ä‡§ï‡•â‡§™‡•ç‡§ü‡§∞ ‡§¶‡•ç‡§µ‡§æ‡§∞‡§æ ‡§™‡•Ç‡§∞‡•á ‡§Æ‡§ß‡•ç‡§Ø‡§™‡•ç‡§∞‡§¶‡•á‡§∂ ‡§Æ‡•á‡§Ç Remdesivir ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§ï‡•Ä ‡§Ü‡§™‡•Ç‡§∞‡•ç‡§§‡§ø ‡§ï‡•Ä ‡§ó‡§à ‡§π‡•à‡•§ #MPFightsCorona,@AbhishekKSarda @ApurwaGhosh_ @COVID19_INDIA @srinivasiyc @AskThePankazzzz The toll free number of CIPLA company is 8657311088 (24 Hrs).  Patients who need Remdisivir injections will be supplied directly to the hospital.  There will be no dealers / distributors / hospitals in. between.,In Mumbai, stores under Pradhan Mantri Janaushadhi Pariyojana have Remdesivir and Cipla said they'll get it in next 2-3 days Please send us any COVID help info on WhatsApp no. 7021955944 and we will verify it,Closing Bell: Market ends higher ; Sensex tops over 500 pts; Nifty above 14,450 levels. Gainers: Axis Bank (+4%), JSW Steel, Ultra Cement (+3%). Losers: Cipla, Britannia, HCL Tech (-2%).  https://t.co/xHc2kybTdh #Nifty #Sensex #StockMarket #Stocks,Nifty Pharma trades flat as heavyweights Lupin, Cipla drag; Cadila, Divi's Labs top gainers  https://t.co/suBBUq8pLD #Nifty #niftypharma #sensex #StockMarket #StocksToWatch #stocks #lupin #cipla #cadila #DIVISLAB,@Radhika_Khera Hugggs. I got this   The Cipla Helpline #Tocilizumab  Contact Details: 022-62820886 | 8657311088 | info.availability@cipla.com we just have to check if it works.,@curioabhi @NadjaNadika @ummmrita @Ofeeeliaaaa @nehabuch @80Vivek08 @DilliDurAst @Ashutoshnandwan @rakhitripathi @GautamBhan80 @mleccha @vqueeram @rituparnaborah Let me know   if the Cipla Helpline works. I,@curioabhi The Cipla Helpline #Tocilizumab  Contact Details: 022-62820886 | 8657311088 | info.availability@cipla.com"
2021-04-27,912.4000244140624,913.0,919.5,901.0,5669049.0,"Given to understand that Tocilizumab stock will be available in Mumbai, starting tomorrow. Roche seems to have shipped it and now the ball is in Cipla's court as regards distribution.   Hope it all falls in place.,@kalpeshravals @Roche @Cipla_Global Sir, let‚Äôs spread awareness so people don‚Äôt feel that their relative died because they couldn‚Äôt manage to get this injection üôèüèº,‚ÄúCorrect me if I am wrong‚Äù about #Tocilizumab .. There is an extreme shortage of this injection. It‚Äôs manufactured by @Roche and @Cipla_Global is the importer. Only they can confirm the new stock availability üôèüèº @drrajivguptaias @Mukeshias @AmdavadAMC     https://t.co/YqyDQXR328,To meet high demand of #Tocilizumab across the country because of sharp rise in Covid 19 cases, an interim allocation of this drug among states has been finalized jointly by @MoHFW_INDIA and @Pharmadept in consultation with Cipla Ltd.  @PIB_India @PMOIndia @Cipla_Global,Merck &amp; Co Inc (MRK.N) said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd (CIPL.NS) and Sun Pharmaceutical Industries Ltd (SUN.NS), to expand production and access to its experimental COVID-19 drug.‚Äã  https://t.co/T6G3DQvVT2,Drugmaker, Cipla Quality Chemical Industries Limited (Cipla) has reported that it has now secured about 30 African markets to supply its lifesaving medicines.   https://t.co/3UVDRP2X9i | #VisionUpdates | #NewVisionAt35,Are there any other options we can explore in the short-term to step up India's #COVID19 #vaccine stock, asks @tanvishukla   @grumpeoldman, Former Global General Counsel Of Cipla &amp; Glenmark, gives a 2-step solution! WATCH!  https://t.co/h4hIrQLFyC,MSD has signed agreements with Cipla Ltd., Dr. Reddy‚Äôs Laboratories, Emcure Pharmaceuticals Ltd., Hetero Labs Ltd. and Sun Pharmaceutical Industries Ltd  https://t.co/deepjfDIft,Court: Second method pears to be of procuring vials through tender notice. On April 21, this court was informed by Divisional Commissioner Nagpur that bids are received from bidders and CIPLA as lowest bidder was considered for being issued the order of supply of Remdesivir.,Merck &amp; Co Inc (MRK.N) said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd (CIPL.NS) and Sun Pharmaceutical Industries Ltd (SUN.NS), to expand production and access to its experimental COVID-19 drug.‚Äã  https://t.co/3BBMJ0SOER,The voluntary licensees are Cipla, Dr Reddy‚Äôs Laboratories, Emcure Pharmaceuticals, Hetero Labs, and Sun Pharma.  https://t.co/LgaH33JbvN,Never imagined ever that we countrymen wud be so helpless one day @Cipla_Global,#Delhi   Cipla Tocilizumab injunction Actemra Name Suchika Singh 40yrs Female  In YATHAARTH HOSIPITAL  Contact Person üëá Ashish Singh +91 98118 49774,Need urgently  Cipla Tocilizumab injunction Actemra Name Suchika Singh 40yrs Female  In YATHAARTH HOSIPITAL  Contact Person üëá Ashish Singh +91 98118 49774  @The_NehaJoshi @CharuPragya @TajinderBagga,A day after Natco filed for emergency use approval of #molnupiravir in India, US drug maker Merck announces voluntary licensing agreements with 5 Indian drug makers - Dr. Reddy's, Sun Pharma, Cipla, Hetero and Emcure. Deal includes supplies to India and over 100 LMICs.,K Sujatha Rao: ‚ÄúThis is not the time to create monopolies and allow profiteering. Instead, this is the CIPLA moment when it took on the MNCs and crashed the market of HIV/AIDS drugs from USD12,000 to USD300‚Ä¶ Needed is a commitment to peoples‚Äô welfare.‚Äù  https://t.co/usfKxCxAMR,Thrs dire need of #Tocilizumab400 in the country and sadly it's not available anywhere in the country....What preparedness do we talk about ? Cant we please advance the shipment to Metros like Delhi/NCR, Mumbai and elsewhere @cipl @Cipla_Global @Roche @CDCDirector,MSD Pharma, arm of Merck &amp; co has signed voluntary licensing agreements with Cipla, Dr Reddy‚Äôs, EMCURE Pharma, Hetero Labs &amp; Sun Pharma for Molnupiravir, an investigational oral therapeutic for the treatment of #COVID19  https://t.co/gF438HCseI,Nifty Pharma joins markets bullish bandwagon, index surges; Divi's Lab, Lupin, Cipla lift the performance  https://t.co/a7mJnM9OFB #Nifty #niftypharma #sensex #StockMarket #StocksToWatch #stocks #divislab #lupin #cipla"
2021-04-28,910.2000122070312,914.3499755859376,918.0,902.9500122070312,7251009.0,"Cipla ties up with MSD to make, distribute investigational drug molnupiravir in India   https://t.co/mycaMjqjHG,Cipla inks deal with MSD to manufacture and distribute Covid-19 drug  https://t.co/xi4Choqusk #cipla,Government @Pharmadept sets allocation of #tocilizumab to states amid shortage  @Roche @Cipla_Global #COVID19India  https://t.co/mOqMl2K3Zg,AMU VC requests the Chairman of Cipla for 1000 Remdesivir Injection @PIB_India @DG_PIB @PIBHRD @DrRPNishank @drharshvardhan @SanjayDhotreMP @ProfTariqManso1 @PMOIndia @rashtrapatibhvn @EduMinOfIndia @ugc_india @MoHFW_INDIA @COVIDNewsByMIB @mygovindia @AwasthiAwanishK @amualumni  https://t.co/9XOuMniq89,‡™ü‡´ã‡™∏‡´Ä‡™≤‡´Ä‡™ù‡´Ç‡™Æ‡´á‡™¨ ‡™à‡™®‡´ç‡™ú‡´á‡™ï‡´ç‡™∂‡™® ‡™≠‡™æ‡™∞‡™§‡™Æ‡™æ‡™Ç ‡™¨‡™®‡™§‡™æ ‡™®‡™•‡´Ä,  cipla ‡™è‡™®‡´Ä ‡™Ü‡™Ø‡™æ‡™§ ‡™ï‡™∞‡´á ‡™õ‡´á ‡™™‡™∞‡™Ç‡™§‡´Å ‡™≠‡™æ‡™∞‡™§‡™Æ‡™æ‡™Ç ‡™è ‡™ñ‡´Ç‡™ü‡´Ä ‡™™‡™°‡´ç‡™Ø‡™æ ‡™õ‡´á.  ‡™Ü ‡™µ‡´Ä‡™°‡™ø‡™Ø‡´ã‡™Æ‡™æ‡™Ç ‡™•‡´ã‡™°‡´Ä ‡™ú‡™æ‡™£‡™ï‡™æ‡™∞‡´Ä ‡™Ü‡™™‡™µ‡™æ‡™®‡´ã ‡™™‡´ç‡™∞‡™Ø‡™§‡´ç‡™® ‡™ï‡™∞‡´ç‡™Ø‡´ã ‡™õ‡´á.   ‡™Ö‡™´‡™µ‡™æ ‡™Ö‡™®‡´á ‡™®‡™ï‡™æ‡™∞‡™æ‡™§‡´ç‡™Æ‡™ï ‡™â‡™∞‡´ç‡™ú‡™æ‡™•‡´Ä ‡™¶‡´Ç‡™∞ ‡™∞‡™π‡´ã,  ‡™∏‡´ç‡™µ‡™∏‡´ç‡™• ‡™∞‡™π‡´ã..  - ‡™Ö‡™¶‡™ø‡™§‡™ø ‡™∞‡™æ‡™µ‡™≤   https://t.co/YqyDQXR328,Dr Reddy's Lab, Sun Pharma, Cipla among 5 firms in license agreement with Merck for Molnupiravir  https://t.co/crcqFJ8grL #DRreddys #SunPharma #cipla,@Cipla_Global @AkhileshKant do you have Remdesivir stock @Cipla_Global?,Cipla gets go-ahead to export drugs to 30 African countries  https://t.co/mWdfoiwCJw #MonitorUpdates,‡≤ü‡≥ä‡≤∏‡≤ø‡≤≤‡≤ø‡≤ú‡≥Å‡≤Æ‡≤æ‡≤¨‡≥ç ‡≤î‡≤∑‡≤ß‡≤ø‡≤Ø ‡≤∏‡≤Æ‡≤∞‡≥ç‡≤™‡≤ï ‡≤™‡≥Ç‡≤∞‡≥à‡≤ï‡≥Ü‡≤ó‡≥Ü, ‡≤∞‡≤æ‡≤ú‡≥ç‡≤Ø‡≤ó‡≤≥ ‡≤®‡≤°‡≥Å‡≤µ‡≥Ü ‡≤î‡≤∑‡≤ß‡≤ø ‡≤π‡≤Ç‡≤ö‡≤ø‡≤ï‡≥Ü‡≤Ø‡≤®‡≥ç‡≤®‡≥Å ‡≤ï‡≥á‡≤Ç‡≤¶‡≥ç‡≤∞ ‡≤∏‡≤∞‡≥ç‡≤ï‡≤æ‡≤∞ ‡≤Ö‡≤Ç‡≤§‡≤ø‡≤Æ‡≤ó‡≥ä‡≤≥‡≤ø‡≤∏‡≤ø‡≤¶‡≥Ü.  #Unite2FightCorona @PIB_India   @PMOIndia   @Cipla_Global,@radical_radika @chintan_connect @rubenmasc @janiceseq85 @satyajeettambe @AUThackeray  https://t.co/zjOBnx5ltG  Just saw this. Am drawing a blank everywhere. Perhaps a connection at Cipla might help.,MSD has signed agreements with Cipla Ltd., Dr. Reddy‚Äôs Laboratories, Emcure Pharmaceuticals Ltd., Hetero Labs Ltd. and Sun Pharmaceutical Industries Ltd  https://t.co/ENnPJ46pH0,Archives | In the early 2000s, Yusuf Hamied, the chairman of Cipla, decided to sell a three-drug ‚Äúcocktail‚Äù therapy for HIV to patients in Africa for just $1 a day. Until then, the treatment cost around $1,000 a year.   @VidyaKrishnan and @MandakiniGahlot:  https://t.co/Gc4CT75VRX  https://t.co/wyLs92Y9Hq,Merck &amp; Co Inc (MRK.N) said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd (CIPL.NS) and Sun Pharmaceutical Industries Ltd (SUN.NS), to expand production and access to its experimental COVID-19 drug.‚Äã  https://t.co/JSs8H2aN82"
2021-04-29,906.5,911.9500122070312,917.4000244140624,904.0,4953091.0,"From Cipla to Cadila, a viral surge caught remdesivir makers off guard. But they‚Äôre catching up now.   https://t.co/2r2OFi5AHx  https://t.co/ihTqApzMSy,The Bombay High Court has dismissed a joint petition filed by Cipla, HDFC Bank NSE 0.27 %, Tata Capital that had challenged formation of co-operative society of the unitholders of Peninsula Business Park in Lower Parel business district of Mumbai    https://t.co/EteY3wVf1v,‚ÄúHe told my wife that he‚Äôs a distributor of Cipla...His WhatsApp display picture was the Cipla Foundation logo,"" says Rishabh Kapur, an advocate.  Kapur paid Rs 40,800 for six vials of Remdesivir but never received the drug.  @DikshaMunjal6 reports.   https://t.co/wnhJU6RmUl,Molnupiravir, the investigational oral antiviral drug being studied for the treatment of non-hospitalised patients with confirmed Covid-19, will now be manufactured and distributed by Cipla  https://t.co/Qfg6PqdhJL,Cipla has shared a file with all its #REMDESIVIR distributors, sharing the ones in #Delhi for #Covid19IndiaHelp¬†Ôøº.  https://t.co/HiKkiD4C3h,From Cipla to Cadila, a viral surge caught remdesivir makers off guard. But they‚Äôre catching up now.    https://t.co/EOIhj0iqdf,ETHealthworld | Stock of #Tocilizumab drug has now been imported and is available with Cipla Ltd (@Cipla_Global) for marketing &amp; distribution in the country  @MoHFW_INDIA @Pharmadept @moayush @NITIAayog   #COVID19India #antiviral #CovidDrugs #toclizumab   https://t.co/g8k0DTX9i8,From Cipla to Cadila, a viral surge caught remdesivir makers off guard. But they're catching up now.    https://t.co/zsHyIXA4Ja,As received on whatsapp from Sohini Gooptu. *FRAUD ALERT* A number +91 76040 27966 by the name of Ajay Agarwal, CIPLA is being circulated across the social media.Please be alerted that this person is fraud, he takes money in advance &amp; afterwards does not reply nor picks the call!"
2021-04-30,910.3499755859376,900.75,921.0,900.75,6459737.0,"@Riss_Chourasia @AasthaSood10 @tmohit18 @ManinderKour1 @KushaKapila @TJhumroo @CiplaFoundation @Cipla_Global @DCP_CCC_Delhi @Cyberpeace_r FYI,@Cipla_Global @MylanNews @SunPharma_Live ‡§™‡•ç‡§∞‡§¶‡•á‡§∂ ‡§Æ‡•á‡§Ç ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§ï‡•Ä ‡§Ü‡§™‡•Ç‡§∞‡•ç‡§§‡§ø ‡§è‡§µ‡§Ç ‡§µ‡§ø‡§§‡§∞‡§£ ‡§™‡§∞ ‡§°‡•ç‡§∞‡§ó ‡§®‡§ø‡§∞‡§ø‡§ï‡•ç‡§∑‡§ï‡•ã‡§Ç ‡§¶‡•ç‡§µ‡§æ‡§∞‡§æ ‡§∏‡§§‡§§ ‡§®‡§ø‡§ó‡§∞‡§æ‡§®‡•Ä ‡§∞‡§ñ‡•Ä ‡§ú‡§æ ‡§∞‡§π‡•Ä ‡§π‡•à‡•§ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§ï‡•á ‡§è‡§Æ‡§Ü‡§∞‡§™‡•Ä ‡§∏‡•á ‡§Ö‡§ß‡§ø‡§ï ‡§¶‡§æ‡§Æ ‡§™‡§∞ ‡§¨‡§ø‡§ï‡•ç‡§∞‡•Ä ‡§è‡§µ‡§Ç ‡§ï‡§æ‡§≤‡§æ ‡§¨‡§æ‡§ú‡§æ‡§∞‡•Ä ‡§™‡§∞ ‡§≠‡•Ä ‡§™‡•ç‡§∞‡§≠‡§æ‡§µ‡•Ä ‡§®‡§ø‡§Ø‡§Ç‡§§‡•ç‡§∞‡§£ ‡§ï‡•á ‡§™‡•ç‡§∞‡§Ø‡§æ‡§∏ ‡§ï‡§ø‡§è ‡§ú‡§æ ‡§∞‡§π‡•á ‡§π‡•à‡§Ç‡•§ #MPFightsCorona,‡§Ü‡§ú ‡§¶‡§µ‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä CIPLA ‡§®‡•á ‡§∞‡§æ‡§ú‡•ç‡§Ø ‡§∏‡§∞‡§ï‡§æ‡§∞ ‡§ï‡•ã ‡§∞‡•á‡§Æ‡§°‡§ø‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§® ‡§ï‡•Ä 600 ‡§°‡•ã‡§ú, MYLAN ‡§®‡•á 8000 ‡§°‡•ã‡§ú ‡§î‡§∞ SUN PHARMA ‡§®‡•á ‡§®‡§ø‡§ú‡•Ä ‡§∏‡§Ç‡§∏‡•ç‡§•‡§æ‡§®‡•ã‡§Ç ‡§ï‡•ã 3600 ‡§°‡•ã‡§ú ‡§ï‡•Ä ‡§Ü‡§™‡•Ç‡§∞‡•ç‡§§‡§ø ‡§ï‡•Ä‡•§ @Cipla_Global @MylanNews @SunPharma_Live  #MPFightsCorona,Waghmare: Will give an example of .@Cipla_Global. It has released around 50,000 vials from its Bhiwandi depot.  It will distribute vials as per requirement pertaining to the percentage of the patients.,@atikachohan @RichaChadha @DevasDixit Remdesivir is not given to patients directly, the hospital has to order it from the Cipla website ...  https://t.co/1w64kb8vk0,#Opinion | The pandemic is a timely and apt reminder to pay heed to our respiratory #health, and particularly the #lungs.  https://t.co/Jpf36JRHMI | ‚úçÔ∏è: UMANG VOHRA, Managing Director and Global CEO, @Cipla_Global  https://t.co/nk68hgQNVW,Every Indian Thank you @Cipla_Global , @ZydusUniverse  , @drreddys , @SunPharma_Live , @heteroofficial , @MylanNews , #jubiliantlifesciences and other companies !  For working hard Day and Night to Manufacture and supply #Remedisivir to save life‚Äôs of People from #COVID19India  !"
2021-05-01,,,,,,"@prasanth_j Called the Cipla number. I got an automated message that it‚Äôs out of stock.,Connect with the digital leaders for an intuitive session at the Digital Transformation Summit scheduled to happen on 05th &amp; 06th May. Register Now:  https://t.co/W625nzPnTv  @AccentureIndia, @HUL_News, @BioconBiologics, @Cipla_Global  #DTS2021 #digitaltransformation  https://t.co/OpdIcsgn2Z,Companies like CIPLA, Amazon, Zomato and PayTM, whose revenue is bound to shoot high because of the pandemic owe it to the country to do more than they do for the people, with the extra margin.  Especially when the government is deep in a bog.  #IndiaCovidCrisis,@Jordarjosh @Cipla_Global @AmitHPanchal Avoid wasting time üôè,Cipla pharmaceutical company has submitted a formal complaint to the Mumbai Cyber Police in the regard.    https://t.co/rrwsZJtJfr"
2021-05-02,,,,,,"""In addition, to the problem of supply, the allocation of #vaccines is poorly done,"" says Murali Neelakantan (@grumpeoldman), Former Global General Counsel of Cipla &amp; Glenmark adding that with the change in policy, our #vaccination rate has gone down &amp; we might never catch up  https://t.co/Lm9C4hq4Qx"
2021-05-03,910.2000122070312,919.0999755859376,924.4000244140624,906.4000244140624,6330144.0,"Woodlands Multispeciality Hospital [COVID Suspects] 033-4033-7000, 07-6040-75551, 07-60407-5552, 07-60407-5553 MEDICINES  CIPLA 86-5731-1088 (info.availability@cipla.com) Sanjay Lohia 98-3100-1951  #CovidResources #KolkataCovidCare,I do not understand why citizens have not filed an avalanche of PILs, demanding Compulsory Licensing under üëáüèæ  @grumpeoldman is a superlawyer is the Global General Counsel, Cipla. LISTEN TO HIM.,Opening Bell: Market opens on a negative note; Sensex falls over 570 pts; Nifty below 14,500-mark. Gainers: ONGC, Cipla (+1%). Losers: SBI, Reliance, HDFC Bank (-2%).  https://t.co/2JtT7sgFMP #nifty50 #sensex #StockToWatch #StockMarket,See #TOPCALLS on @CNBC_Awaaz @CNBCBajar   Buy #TCS3000Put #LTTS #CIPLA  #TataSteel  SELL #Mahindra   @asitbaran @mayureshm_joshi @PrakashGaba @Rajesh_Satpute @tapariachandan @themanasjaiswal   @BhumeetGupta  @virendraonNifty,@shubh456gupta @DCP_CCC_Delhi @COVIDNewsByMIB @Cipla_Global @AamAadmiParty Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXyvXF or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900."
2021-05-04,878.4500122070312,912.9000244140624,912.9000244140624,876.0,8347795.0,"#GrowwDigest: Daily Highlights | 4 May 21 - (1/4)  #Sensex: 48,253.51 ‚ñº 0.95% #Nifty: 14,496.50 ‚ñº 0.94%  üîºTop Gainers (Nifty 50): SBI Life, ONGC, BPCL, Bajaj Finance &amp; Adani Ports üîΩTop Losers (Nifty 50): Tata Consumer, Cipla, Dr Reddy's, Divi's Lab &amp; Reliance  https://t.co/0nhXtYTMNf,Cipla Quality Chemical Industries Limited (Cipla) has issued a profit warning informing shareholders that it will record a loss for the period ended March 31, 2021.   https://t.co/RyuYVkgN1u | #VisionUpdates | #NewVisionAt35,#MarketAtClose | Pharma Is The Top Losing Index; Nifty Pharma Falls More Than 2%  Cipla, Divi‚Äôs, Dr Reddy‚Äôs &amp; Sun Pharma Are Top Nifty Losers  Tata Cons Under Pressure Ahead Of Its Earnings On May 6  https://t.co/WOcuj4mEkU,Closing Bell: Market ends lower; Sensex plunges 465 pts; Nifty settles below 14,500-mark. Gainers: SBI Life (+2%), BPCL, ONGC (+1%). Losers: Tata Consumer (-4%), Cipla (-3%), Dr Reddy (-2%).  https://t.co/b5FM6C9LFx #StockMarket #stocks #StocksToWatch #Nifty,Tuesday's Top Bear! Nifty Pharma sheds over 1%; Cipla, Dr Reddy's Lab, Sun Pharma drag  https://t.co/yfcE0sU3b8 #nifty #niftypharma #sensex #StockMarket #StocksToWatch #stocks #cipla #drreddy #SunPharma,@akshat_kher16 @Cipla_Global @MumbaiPolice Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXyvXF or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900.,@Riss_Chourasia @Cyberdost @DCP_CCC_Delhi @CybercrimeCID @Cipla_Global @RubikaLiyaquat @TJhumroo @AasthaSood10 Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXQ7mf or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900.,@akshat_kher16 @DrSuraj89054293 @Cipla_Global Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXyvXF or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900.,Cipla associate GoApptiv incorporates wholly owned subsidiary Iconphygital  https://t.co/EoalWA4hEf #cipla"
2021-05-05,888.6500244140625,885.0,899.0,869.0,10491085.0,"Should be good news. Well done #Roche and always held #CIPLA in high esteem.    COVID-19 treatment: Roche India gets emergency use approval for antibody cocktail of Casirivimab, Imdevimab | India News  https://t.co/sleDqfKvAb,Roche‚Äôs #Covid19 treatment gets India approval, partner Cipla says.  Read all #coronavirus updates here:  https://t.co/Of9AgSZqRn  https://t.co/vOem3H7Jsa,""This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India and will be marketed as well as distributed in India through a strategic partnership with Cipla Limited,"" it added.   https://t.co/sp2EDzHsE7,Roche India receives Emergency Use Authorisation for #Casirivimab and #Imdevimab in India. Cipla will market and distribute the product in India, @viswanath_pilla reports.  #RochePharma @Cipla_Global #COVID19 #CovidIndia    https://t.co/gACl2yyjyi,Casirivimab and Imdevimab will be marketed in India through a strategic partnership with Cipla Limited #COVID19  https://t.co/tHc6AwC0S0,#COVIDSecondWave | Roche gets #India EUA for investigational antibody cocktail; can #import globally manufactured product batches to India. @Cipla_Global  in partnership with Roche on antibody cocktail distribution (Agencies)  https://t.co/ILHMIQhOYC,Spoke to @Cipla_Global @JubilantBiosys @MylanNews &amp; @SyngeneIntl @kiranshaw about pending delivery of 97000 vials of #Remdesivir before 9th May. I thank them for their assurance to supply without delay.  Instructed drug controllers to give live updates on drug availability.  1/2  https://t.co/hi6v5d8VBq,The best medical advice on the internet is on ¬† #HealthMatters with @CiplaRSA.¬† ¬† I host a new podcast series where experts provide topical healthcare info, with kindness. Because health matters.¬† https://t.co/vdxr7B0TAO  https://t.co/lERqRChzed #CiplaHealthMatters #Cipla,@JayChakrabarti @Regeneron @Roche @Cipla_Global How does that work? Will you please explain...,Thrilled to hear that @Regeneron @Roche are partnering with @Cipla_Global to fast-track last mile delivery of dual-monoclonal antibodies across India in its of time need. Approved today, in arms hopefully by end of week, possibly even via injection and not IV.,Please read #cuppa; not Cipla! Typo,Hibiscus Tea! No milk no sugar; Rachana ji you are welcome for a hot Cipla @Dstreetwinners  https://t.co/JW5akL52ZM,#CIPLA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?  https://t.co/i7JWngzczI  https://t.co/Z3DLi7Sm02"
2021-05-06,884.2999877929688,907.0,916.7000122070312,880.9000244140625,17973153.0,"Basis the telephonic conversation we had yesterday, state received 26000 #Remdesivir vials today surpassing the 10K/day quota. This will help us make it available across districts.  Many thanks to the manufacturers! @Cipla_Global @JubilantBiosys @MylanNews @SyngeneIntl @kiranshaw,Today I visited Kamla Life Sciences Limited, a manufacturing unit for Cipla at Tarapur MIDC in Palghar district &amp; interacted wt the chairman Dr. Digambar Zawar &amp; senior officials of the production dept. that produces #Remedicivir injections used in the treatment of #COVID19 (1/2)  https://t.co/78Eb02eKUJ,@ScottGottliebMD @C_Garthwaite @jbkrell @zainrizvi @akapczynski @cmorten2 @Dereklowe @llborio @PatentScholar @GinaRaimondo @DrTedros @MSF Scott that‚Äôs an overstatement and you know it. Are you suggesting that CIPLA was pushing out fake ARVS in the early 2000s?,J Kulkarni - This is manufactured by Rosche Switzerland and distributed through Cipla in India. But there are other alternatives.   #BombayHC #Covid19 #PIL #Tocilizumab,The EUA will enable Roche to import the globally manufactured product batches to India in a partnership with #Cipla.,Roche bags Emergency Use Authorisation in India for antibody cocktail to treat Covid, Cipla will distribute  https://t.co/CQGTeHwV1p #rochebags #CIPLA,Watch @Bh_Chandra , President, and CEO, @iForestGlobal , throw light on the detrimental aspect of #airpollution on the #lungs since childhood thereby making lungs vulnerable to multiple diseases.  #Cipla #lunghealth #COVID19  https://t.co/nnSEmXqUEs,#Watch Dr. Jaideep Gogtay- #Watch Dr. Jaideep Gogtay, Global Chief Medical Officer, @Cipla_Global talk about respiratory &amp; #lunghealth addressing both indoor &amp; outdoor #airpollution.   https://t.co/90DyXZRC1P  #Cipla #COVID19 #healthcare #pollution #cantbreatheindelhi #airquality,#Watch @Geena_Malhotra, Global Chief Technology Officer, @Cipla_Global, throw light on the challenges &amp; solution on public health issues &amp; the healthcare system.   https://t.co/t3Viz9T7cC  #Airpollution #Cipla #lunghealth #COVID19 #healthcare #pollution #cantbreatheindelhi,India approves Roche's antibody cocktail to treat COVID-19; Cipla to distribute the drug #Roche #COVID19 #CoronaVaccine    https://t.co/JaY3F9BhIl,@Riss_Chourasia @Cyberdost @CrimeBrDelhi @DCP_CCC_Delhi @CiplaFoundation @Cipla_Global @noidapolice @BankofIndia_IN @Bankofindia_BOI @BOI_Tweets Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXyvXF or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900.,#CNBCTV18Market | Cipla, Bajaj Fin &amp; Hindalco amongst top #Nifty gainers  https://t.co/9e9yn2oXdC,#StocksToWatch 1. Cipla: tie up with Roche for covid treatment drug  2. Wipro: deal to transform vaccine dev process  3. IDBI Bk: cabinet nod for strategic disinvestment  4. Strong rslt: Gillette, Tata Steel, Blue Dart  5. Reslts today: Tata Consumer, Hero Moto, Blue Star #nifty,#morning India @MotilalOswalLtd #StocksToWatch  #TataSteel EBITDA rises 50% QoQ to a record high. debt redu., Capex is bk. üëç #SRF strong perfo, margin üëç #Ceat below est.  Ethanol stocks in US up. Sugar stocks üëç #CIPLA Roche‚Äôs Covid Treatment Gets India Approvl,  #Nifty #stocks,#StocksInFocus on May 6: #TataSteel, #DeepakNitrite, #IDBIBank, #Cipla to #TataMotors; here are expected 5 Newsmakers of the Day #PaisaKaiseBanae @AnilSinghvi_   https://t.co/CqIRhl4KeO,Top stocks in focus: Cipla, Wipro, Tata Steel, Adani Group, Hero MotoCorp  https://t.co/12MivDZDhd #nifty #sensex #stockmarkets #StockToWatch #stocks #cipla #wipro #tatasteel #ADANIGROUP #heromotocorp"
2021-05-07,882.9000244140625,893.0,895.5,877.0,5479029.0,"Even today #Tocilizumab is being bought at Rs 4 lakh/vial &amp; Remdesivir at Rs 50K/vial. People are running around with a prescription begging. For God's sake look at this @narendramodi, @drharshvardhan, @arvindkejriwal and all other CMs. CIPLA is NOT supplying even to hospitals.,Fraud Alert!  Beware of this Number - 7797556703 as it claims to be a Cipla Distributor selling Remdesivir on Instant Delivery Basis while cheating others through this trap! The no. is going viral in Hyderabad so please stay alert and don't be a part in spreading #fakedetails !!,#MarketThisWeek | Except Realty, All Sectoral Indices Post Gains This Week  Tata Steel, Hindalco, SBI Life, Bharti Airtel, JSW Steel Top Nifty Gainers This Week  Tata Cons, RIL, Titan, Cipla, Power Grid Top Nifty Losers This Week  https://t.co/PBxVvQinek,#ETNOWSpecial | Why is biosimilars an exciting space? What is attractive about Cipla? What is in the COVID portfolio of Indian #pharma players? Nithya Balasubramanian of Sanford Bernstein gives the details  @NithyaBala84 @nikunjdalmia @ayeshafaridi1 #COVIDSecondWave  https://t.co/1UDVc3BJrz,@journomayank @nandinigaur @Cipla_Global Still not there?"
2021-05-09,,,,,,"@MITPAR @AUThackeray @CiplaFoundation @Cipla_Global @Suhelseth @mybmc If patient critical please call our helpline 7718812200.  Please send us patient details as below:  Patient Name: Patient Age, Gender:  Date when covid positive: Oxygen Sat: Current location: Patient's Relative's Name &amp; No: Requirement:,How to supply high-quality, affordable medicines? ü§î As one of the first Indian #pharma companies @Cipla_Global is taking a pioneer role in introducing continuous #mfg in its processes! üíä Get the full story:  https://t.co/LNLIhWYEoV #automation #pharmaceutical  https://t.co/oswk4mobDi"
2021-05-10,900.25,892.5,906.4500122070312,877.5,8379304.0,"@malviyapankaj @Leopard212 @salonayyy @Cipla_Global As for actual timeline, one Divisional Commissioner told me that he approved within 15 minutes of getting a genuine request!,@malviyapankaj @Leopard212 @salonayyy @Cipla_Global Total quantity of 9900 for the whole country (may perhaps go up by 3 times) is severely limited for a country of our size. So, there can definitely not be a timeline. Some will get while others won't as there is a high demand. So, docs have to be very meticulous while prescribing,@salonayyy Limited quantity of #Tocilizumab imported by @Cipla_Global is to be given only to private &amp; Govt hospitals thru the State Govts.  https://t.co/slq8U2OWO4. It is to be given in very specific conditions. So, the doctor must check &amp; then requisition along with relevant test reports.  https://t.co/ciUrMDdNch,Drug firm Eli Lilly and Company said it has inked voluntary licensing agreements with Indian drug firms -- Sun Pharma, Cipla and Lupin -- to expedite availability of its arthritis drug Baricitinib for treatment of #COVID19 patients in India.   https://t.co/vfOaP2DFcC,Uttarakhand Health Secy Amit Negi tells High Court that there was a shortfall of over 8000 Remdesivir injections due to Uttarakhand state because of delay by Cipla.  #Uttarakhand #Remdesivir,Eli Lilly inks licensing deal with Cipla, Lupin, Sun Pharma for Baricitinib to treat Covid   https://t.co/ze0JIiWbBg,#BLMarkets : The shares of @Cipla_Global Limited gained over 2 per cent   https://t.co/FarRgNnTpk,Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India #ETIndustryNews  https://t.co/ZxdY5MpTnV,India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19 #ETIndustryNews  https://t.co/eiD2OH4NPh,.@Cipla_Global inks pact with @EliLillyCo to produce, sell #COVID19 drug #Cipla #EliLilly  https://t.co/Ff14j14UpR,Drug major #Cipla on Monday said it has inked a pact with US-based Eli Lilly and Company to manufacture and produce baricitinib in the country for the treatment of #Covid19  #CoronavirusPandemic #Covid19 #Coronavirus   https://t.co/hRYbgipXpd,Eli Lilly gives royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharma for baricitinib  https://t.co/RJ9hCgRXvL @suchetadalal @Moneylifers @yogtoday  via  https://t.co/oCY4nE2wqz,US company Eli Lilly and Co said it signed licensing deals with Indian drugmakers, such as Cipla Ltd, Lupin and Sun Pharma to make and sell its arthritis drug baricitinib for the treatment of Covid-19 patients.   https://t.co/jpVcfABdSV,#Cipla ‡§ï‡§æ #EliLilly ‡§ï‡•á ‡§∏‡§æ‡§• ‡§≤‡§æ‡§á‡§∏‡•á‡§Ç‡§∏‡§ø‡§Ç‡§ó ‡§ï‡§∞‡§æ‡§∞, ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡•Ä #Baricitinib ‡§¶‡§µ‡§æ ‡§ï‡•ã ‡§ï‡•ã‡§µ‡§ø‡§° ‡§ï‡•á ‡§ü‡•ç‡§∞‡•Ä‡§ü‡§Æ‡•á‡§Ç‡§ü ‡§ï‡•á ‡§≤‡§ø‡§è ‡§¨‡•á‡§ö‡•á‡§ó‡•Ä    https://t.co/J8vF8dR41B,COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India  https://t.co/nGOoOCiFxl,Cipla inks pact with Eli Lilly to produce, sell COVID-19 treatment drug  https://t.co/0bCRtwScnd,ETHealthworld | Indian drugmaker @Cipla_Global had entered into a licensing agreement with U.S. company Eli Lilly and Co to make &amp; sell Lilly's arthritis drug #baricitinib for the treatment of #Covidpatients   @LillyPad  #COVIDTreatments #pharmaceuticals    https://t.co/vKT4tSlHi2,Coronavirus: Cipla inks pact with Eli Lilly to produce, sell COVID-19 treatment drug   https://t.co/6s0mkuQv5v #Coronavirus,Cipla will leverage its extensive distribution footprint to make this therapy accessible to more patients and markets, it said.   https://t.co/4J3uKNZez1,Cipla announced that it has signed an agreement with Eli Lilly and Company to manufacture baricitinib for COVID-19 treatment.    https://t.co/mQAeFuUAYq,Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19  https://t.co/n5HDp6cCkw,India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19  https://t.co/JtOul5M1KI  https://t.co/BEJhl1yHZD,Cipla, Lupin, Sun Pharma to make, sell low-cost versions of Lilly's #COVID19 drug @joecmathew  https://t.co/3EhAH62LhG,#Cipla's deal with #EliLilly expands its portfolio of #COVID-19 drugs. #CovidIndia #COVIDSecondWave   https://t.co/dgDCujIpyP,Cipla's deal with Lilly expands the Indian drugmaker's portfolio of #Covid19 drugs   https://t.co/fVtzAnBNEP,Cipla to make, sell Eli Lilly's baricitinib for Covid-19 treatment  https://t.co/X6Og6XKQwp,Cipla signs agreement with Eli Lilly to expand access of Baricitinib drug  https://t.co/GZQkfIacZS #cipla,Drugmaker #Cipla Ltd said on Monday it had entered into a licensing agreement with #US company Eli Lilly and Co to make and sell Lilly‚Äôs arthritis drug baricitinib for the treatment of #COVID19 patients.  https://t.co/0EP8EN2ZTN,#Cipla ties up with #EliLilly to make, sell #Baricitinib to treat #COVID19 patients in India  https://t.co/Tmy1QYcoJm via @BT_India,Cipla to make and sell Eli Lilly's baricitinib to treat Covid-19  https://t.co/67XOwuHOOV,Cipla Enters Into Licensing Agreement With US Company For Key Covid Drug  https://t.co/Atn5MaDLeh  https://t.co/G7fSdicJ4t,Opening Bell: Indices open higher; Sensex rises over 300 pts; Nifty trades above 14,900-mark. Gainers: Tata Steel (+3%), Dr Reddy, Hindalco, UPL (+2%). Losers: Ultra Cement (-1%), Heromoto Corp, Cipla stocks down marginally.   https://t.co/FhU6RNj1pm #StockMarket #Nifty #stocks,Eli Lily has signed a voluntary licensing agreement with Cipla, Lupin and Sun Pharma for the Baricitinib drug in India. @ekta_batra gets the details  https://t.co/FQoWF2legU,#StocksInNews | @Cipla_Global in licensing pact with Eli Lilly for #COVID19 treatment in #India; pact for Baricitinib for COVID-19 indication (Agencies)   #COVIDSecondWave  https://t.co/6J1m2eUkmW,#CIPLA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?  https://t.co/hicSS3ODbT  https://t.co/dIPbiKbldE,Eli Lilly issues royalty-free, non-excl voluntary licenses to Indian cos including Cipla, Lupin &amp; Sun Pharma for Baricitinib. It‚Äôs also in discussions with other cos for grant of licence Alert: Eli Lilly recently got DCGI nod for baricitinib to be used for COVID treatment  https://t.co/OaWK6heohV,‡™®‡´ç‡™Ø‡´Å‡™ù ‡™´‡´ç‡™≤‡´á‡™∂ : ‡™≠‡™æ‡™∞‡™§‡™Æ‡™æ‡™Ç Baricitinib ‡™Æ‡™æ‡™ü‡´á Eli Lily ‡™è  Cipla, Lupin &amp; Sun Ph ‡™∏‡™æ‡™•‡´á ‡™ï‡™∞‡™æ‡™∞ ‡™ï‡™∞‡´ç‡™Ø‡™æ"
2021-05-11,890.9000244140625,899.9500122070312,905.9500122070312,888.2000122070312,5864464.0,"@odonelorza2011 Recuerdo las negociaciones con Cipla y Rambaxy,Karnataka govt warns Cipla, Jubilant with legal action if they fail to fulfill the supply obligation of Remdesivir within 24 hours.   #Karnataka #COVID19 #Remdesivir   https://t.co/cxt3CRVfWD,Cipla and Jubilant were ordered to supply 30,000 and 32,000 vials respectively by May 9. However, they supplied only 10,840 and 17,601 vials on May 8.  #Karnataka #Remdesivir  https://t.co/TpJT5lp69E,Karnataka asks Cipla to fulfil supply obligation of Remdesivir within 24 hours or face legal action  @MugdhaCNBCTV18  https://t.co/H9zp48cvOC,Mumbai: Khar bizman duped of Rs 40,800 for Remdesivir vials by man posing as Cipla Foundation employee, @Priyanka_Scribe reports   @CiplaFoundation #Remdesivir #COVID19 #Mumbai #cipla    https://t.co/t5x47YDpoo,Indian Economy News: 11-05-21  1. India-EU leaders‚Äô meeting gives new momentum to ties 2. Cipla, Lupin, Sun Pharma sign deals to make Lilly‚Äôs Covid drug 3. Twitter donates USD 15 million for Covid relief in India &amp; more   Read hereüëâüèº  https://t.co/FIf0ndMThd  https://t.co/LDnYaRWlU0,#morning India @MotilalOswalLtd #StocksToWatch  #Cipla #SunPharma #Lupin  inks pacts - #Lilly 's covid drug. Auto dealers predict slow sales recovery. üëé New Idea #Solara Active - PT 2000. Positive guid by BMW for nxt yr - #Tatamotors #motherson , Endurance Techüëç #Nifty #stocks,Cipla, Lupin, Sun Pharma sign deals to make Lilly‚Äôs Covid drug   https://t.co/Sw2jrLadUl  https://t.co/7gR9xF4vvI,Cipla, Lupin, Sun Pharma sign deals to make Lilly‚Äôs Covid drug  https://t.co/tuhcAa9Z1I,Cipla's deal with Lilly expands the Indian drugmaker's portfolio of #Covid19 drugs   https://t.co/fVtzAnBNEP"
2021-05-12,898.5999755859375,889.2999877929688,906.75,884.2999877929688,5224240.0,"@bikashk00435226 @hvgoenka @anandmahindra @adarpoonawalla @Cipla_Global @BharatBiotech Thanks Bikash.,Heartiest congratulations to the team @Cipla_Global for winning the #e4mPlay 2021 GOLD for their campaign Healthcare Superstars under the category Best Use of Video Marketing on Digital / OTT Platform by a Brand (Others).  https://t.co/aCSPGhaDRa,Story of #AlexanderFlemming #Penicillin , #WinstonChurchill And #PATENTS  EXCELLENT  @hvgoenka @anandmahindra @adarpoonawalla @Cipla_Global @BharatBiotech  https://t.co/GSTa1uZjCF,Is the move to waive intellectual property rights for Covid-19 vaccines the best way to help combat the rising spread in some countries? Umang Vohra of Cipla suggests that we should focus on fixing access issues first.  https://t.co/SnA31W2Lfa,A sore throat, a cough or headache didn‚Äôt cause as much panic as it does now. Is it Covid, a cold or a flu? I get advice from Dr Shaunagh Emanuel on Health Matters, a podcast by @CiplaRSA  Listen here:  https://t.co/hShwzeJ7ih Or:  https://t.co/X9iRyzT0uF #HealthMatters #Cipla,COVID: Karnataka govt raps Cipla, Jubilant for not delivering committed Remdesivir doses  https://t.co/r1t71xbPfo,#4QWithCNBCTV18 | Pharma majors, Cipla and DRL will report their Q4 numbers on Friday. @ekta_batra gets the street expectations  https://t.co/HaW6IpJ4bR,Karnataka sends notice to Jubilant, Cipla for not supplying allocated Remdesivir doses #Karnataka #REMDESIVIR #COVID19  https://t.co/bDnPjfUVvO,#Q4WithAwaaz | ‡§¨‡§æ‡§ú‡§æ‡§∞ ‡§ï‡•Ä ‡§®‡§ú‡§∞ #DRREDDY, #Cipla ‡§ï‡•á ‡§®‡§§‡•Ä‡§ú‡•ã‡§Ç ‡§™‡§∞ ‡§π‡•à‡•§ ‡§ï‡•à‡§∏‡•á ‡§π‡•ã‡§Ç‡§ó‡•á ‡§®‡§§‡•Ä‡§ú‡•á ‡§¨‡§§‡§æ‡§®‡•á ‡§ï‡•á ‡§≤‡§ø‡§è ‡§π‡§Æ‡§æ‡§∞‡•á ‡§∏‡§æ‡§• ‡§π‡•à‡§Ç @deepaliranaa  https://t.co/aMIQBHsqLl,Court asks Petitioners if there is any information they have on the status of Remdesivir supply.   Purohit submits that Cipla is the only manufacturer supplying Remdesivir.  He submits on the point of manner of prescribing the drug.   Court: This is subjective.,Adv Simil Purohit for Petitioner of Snehal Marjadi says that definitely there is a short supply of the drug.   Says that only Cipla has listed its distributors on its website.  #BombayHC #PIL #Covid19India #CovidManagement,From listed plays.....Cipla and Gufic bio make this product....used for treatment of Black Fungus  https://t.co/CFSydyramb,As the Remdesivir shortage becomes acute and patients struggle to source the drug, the Karnataka Govt has threatened legal action against Cipla, Jubilant Pharmova for not fulfilling supply obligations. @MugdhaCNBCTV18 reports  https://t.co/3Ir16K5hwW,‡ÆÆ‡Æ§‡Øç‡Æ§‡Æø‡ÆØ ‡ÆÖ‡Æ∞‡Æö‡Ææ‡Æ≤‡Øç ‡Æï‡Æ∞‡Øç‡Æ®‡Ææ‡Æü‡Æï ‡ÆÆ‡Ææ‡Æ®‡Æø‡Æ≤‡Æ§‡Øç‡Æ§‡Æø‡Æ±‡Øç‡Æï‡ØÅ ‡Æí‡Æ§‡ØÅ‡Æï‡Øç‡Æï‡Æ™‡Øç‡Æ™‡Æü‡Øç‡Æü‡ØÅ‡Æ≥‡Øç‡Æ≥ ‡Æ∞‡ØÜ‡ÆÆ‡Øç‡Æü‡ØÜ‡Æö‡Æø‡Æµ‡Æø‡Æ∞‡Øç ‡ÆÆ‡Æ∞‡ØÅ‡Æ®‡Øç‡Æ§‡ØÅ‡Æï‡Æ≥‡Øà 24 ‡ÆÆ‡Æ£‡Æø ‡Æ®‡Øá‡Æ∞‡Æ§‡Øç‡Æ§‡Æø‡Æ±‡Øç‡Æï‡ØÅ‡Æ≥‡Øç ‡Æâ‡Æü‡Æ©‡Øá ‡Æµ‡Æø‡Æ®‡Æø‡ÆØ‡Øã‡Æï‡Æø‡Æï‡Øç‡Æï ‡Æµ‡Øá‡Æ£‡Øç‡Æü‡ØÅ‡ÆÆ‡Øç ‡Æé‡Æ©‡Øç‡Æ±‡ØÅ ‡ÆÖ‡Æ§‡Æø‡Æ≤‡Øç ‡Æï‡ØÅ‡Æ±‡Æø‡Æ™‡Øç‡Æ™‡Æø‡Æü‡Æ™‡Øç‡Æ™‡Æü‡Øç‡Æü‡Æø‡Æ∞‡ØÅ‡Æ®‡Øç‡Æ§‡Æ§‡ØÅ.  #Remdesivir #Cipla #Karnataka    https://t.co/H4KTkShBrm,Stocks to watch out: Cipla, Jubilant Life Sciences, Godrej Consumer Products, Siemens, Dr Reddy's among others    https://t.co/8IkYlZras2"
2021-05-13,,,,,,"@vishakhatalreja Hi @vishakhatalreja update :   Injections are not available for open cell   Hospitals need  order via email to cipla   Cipla will make it available to area distributor within 12 hrs   Docs decide 5 per day or  how many are needed  Cost Is rs 3500 to 4000 per injection,Pharma majors Cipla and Jubilant resumed supplying anti-viral drug Remdesivir in Karnataka a day after the state government warned them of legal action if they failed to deliver in 24 hours, said state Revenue Minister R. Ashoka on Wednesday.  https://t.co/RP7EioWeHq,On May 10, #EliLilly had given license agreements to #Cipla, #Lupin and #SunPharmaceuticalIndustries.  https://t.co/LgESC1d64e"
2021-05-14,904.0499877929688,909.0,921.0,900.7999877929688,15048471.0,"#Cipla Q4 profit up 73% at Rs 412 crore, total revenue at Rs 4,606 crore  #Q4FY21  #Q4results    https://t.co/IAfkQ9qbVq,Cipla Q4 Net profit = Rs 413.4 cr for the Jan-March quarter. This is a 68% rise from the same quarter last year.  Dividend of Rs 5 for FY 2020-21.,#EarningsWithMC: Cipla clocks a healthy 72.2% YoY growth in consolidated profit at Rs 411.5 crore driven by operating performance. ‚§µÔ∏è  @Cipla_Global #Cipla #Earnings #Results    https://t.co/QEZSyzA8g9,Results: Cipla Q4 profit up 73% at Rs 412 crore    https://t.co/xw5iYGOV7a,Cipla net profit surges 73% to Rs 412 crore in Q4 on robust sales  https://t.co/RPst4fgydv,Now, Glenmark, Cipla, Sun Pharma In Talks With Foreign Vaccine Makers - Short Post  https://t.co/8LrLew3yZO,#4QWithCNBCTV18 | Cipla's profit and operational margin increase substantially from the same quarter last year.  https://t.co/9nST32As1t,What is the chance that when 100 governments in the world don‚Äôt (yet) have vaccines, a state in India is going to be able to bid for a vaccine? Is that even realistic?: Murali Neelakantan, former global counsel for Cipla and Glenmar. #Covid19India  https://t.co/6AfxcCdtXS,#4QWithCNBCTV18 | Cipla's Q4 earnings miss our estimates.  https://t.co/i9MOQq0lJ7,#EarningsWithETNOW | Cipla Q4: PAT at Rs 413 cr vs ET NOW poll of Rs 620 cr. Revenue at Rs 4,606 cr vs ET NOW poll of Rs 5,009 cr @Cipla_Global  https://t.co/COUhKgvWrT,#EarningsWithETNOW | CIPLA reports Q4 numbers! (Consolidated, YoY) - Revenue from operations at RS 4,606 cr vs Rs 4,376 cr  - Profit attributed to shareholders at Rs 413 cr vs Rs 246 cr  - EBITDA at Rs 796 cr vs Rs 633 cr  - Margin at 17.3% vs 14.4%  @Cipla_Global  https://t.co/3PSs5G7XDV,#4QWithCNBCTV18 | Cipla reports Q4 profit at Rs 411.5 cr.  https://t.co/KbpeMDTJ72,@reachhimmat @Cipla_Global @CiplaFoundation @ArvindKejriwal @msisodia @CMODelhi @CPDelhi Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXyvXF or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900.,.@remodsouza shared the viral ""Cipla company ka Remo D‚ÄôSouza"" video on his social media account.   #Remodsouza #Ciplakaremodsouza #Remdesivir     https://t.co/mw3wwDO7jR,@BeingSodhi @Cipla_Global @TeamSaath Please see all the replies to this post, there are a couple of leads. Hope it helps.,@Ankit__Mishraaa @sushant_says @Cipla_Global @TeamSaath @KumariRukshmani ‡§á‡§®‡§∏‡•á ‡§¨‡§æ‡§§ ‡§π‡•ã ‡§ó‡§à ‡§π‡•à ‡§µ‡•ç‡§Ø‡§µ‡§∏‡•ç‡§•‡§æ ‡§ï‡•Ä ‡§ú‡§æ ‡§∞‡§π‡•Ä ‡§π‡•à‡•§,Hi @Cipla_Global could you please guide here? @TeamSaath,please help @PratyayaIAS @DM_Begusarai @Cipla_Global,Top stocks in focus: JSPL, UPL, Infosys, Torrent Pharma, L&amp;T, Cipla, Dr. Reddy's  https://t.co/QJQtXQIOzV #StockMarket #stocks,#MarketsWithETNOW | Top stocks to watch out for: @DrReddys, Cipla, Larsen &amp; Toubro and more  @vinnii_motiwala  https://t.co/3563Mhr7L4,L&amp;T, #Cipla, #Lupin, Dr Reddy's, Vedanta, GAIL, Tata Power, #Reliance Infrastructure #StocksInFocus #stocks #StockMarket #StocksToWatch   https://t.co/yLGvEj54m9,#ComingUp | #ETNOWPodcastüéôÔ∏è -Gap between Covishield doses set to go up to 12-16 weeks  -#India CPI #inflation eases in April  -US #jobless claims hit pandemic low -All eyes on @drreddys and @Cipla_Global results  Rise With India podcast:  https://t.co/zsRExhJAoo  @alexandermats  https://t.co/vRXFhZq02D,Mumbai: Cipla files complaint against e-sale of fake Covid meds  https://t.co/xYIlBDHgqS,Mumbai: Cipla files complaint against e-sale of fake Covid meds  https://t.co/atrljCfmxA,#ICYMI Pharma majors Cipla and Jubilant resumed supplying anti-viral drug Remdesivir in Karnataka a day after the state government warned them of legal action if they failed to deliver in 24 hours, said state Revenue Minister R. Ashoka on Wednesday.  https://t.co/jD4EgBq832,@archanajsr @Piyushr67158183 @CNBCTV18Live @rocheindia @Cipla_Global Let me check Archana."
2021-05-15,,,,,,"India's Cipla says supply of Covid-19 drug remdesivir catching up with demand  https://t.co/xiMlR1iz2S,India's Cipla said that its manufacturing of the #Covid19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country   https://t.co/vNKUBuna3D,India's Cipla (CIPL.NS) said on Saturday that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country.‚Äã  https://t.co/QbPF0fKx7b,#India‚Äôs Cipla says that its manufacturing of the COVID-19 #remdesivir drug is beginning to catch up with demand after the company sought to boost production amid a massive second wave of #coronavirus infections in the country.   https://t.co/dlLF6zOJRK,India's Cipla said that its manufacturing of the #Covid19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country   https://t.co/vNKUBuEKVb,India's Cipla says supply of Covid-19 drug remdesivir catching up with demand  https://t.co/4D7BX2CL8M,India's Cipla says supply of COVID-19 drug remdesivir catching up with demand  https://t.co/ODe6JIAAoD  https://t.co/VzrvV6Pmlt,Cipla de India dice que el suministro de remdesivir, medicamento COVID-19, est√° alcanzando la demanda.  https://t.co/8nY1N2WZ01,""Cipla company ka Remo D‚ÄôSouza.‚Äù    https://t.co/SvgUXQ7LiN,COVID-19: Supply of Remdesivir catching up with demand, says Cipla   https://t.co/YBvQsXXq79,Cipla says supply of Covid-19 drug remdesivir catching up with demand  #remdesivir #Coronavirus   https://t.co/TFwUE6pYFB,""You got the prioritisation right, but you‚Äôre in a crisis on allocation.""  Murali Neelakantan (@grumpeoldman), former global general counsel at Cipla and Dr. Ashish Kulkarni (@ashish2727) from Gokhale Institute in conversation with Scroll's @RohanV.    https://t.co/gHtCdlPy8c,@ilabehal I am grateful üôè  I could help . I hope the patient recovers . Thank you also to Cipla üôè‚ù§ü§óüôè,India's Cipla said that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country  https://t.co/7iFvc42p2q,India's Cipla says supply of COVID-19 drug remdesivir catching up with demand  https://t.co/bkD2Gg8oSJ  https://t.co/CS23iv6gC4,India's Cipla (CIPL.NS) said on Saturday that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country.‚Äã  https://t.co/dzxd9v0ZHd,@CiplaFoundation @AkshathaMandadi @NeurologyGuy @satishkreddy @KTRoffice @KTRTRS @HeteroHCL @TelanganaCMO @revanth_anumula @seethakkaMLA @srinivasiyc @HansrajMeena @Collector_WGLU @IYCTelangana @naini_rajender @heteroofficial @Cipla_Global @ciplacsi2014 @drreddys Thank you for the clarification.  Our team has been trying to reach Drugs Control &amp; DME for the last 2 days. Attached the screenshot.  We understand the govt is battling a crisis, but matters relating to life saving drugs &amp; it's supply chain need to be known to people.  üôè  https://t.co/VfB7Hk4qcF,@ndtv Remdesivir.... You are in the queue  SARS-CoV2 Virus.... For sure  Such a huge crowd during deadly Pandemic! Why shouldn't Cipla Distributor or State Government agency just deliver the stuff to hospital based on doctor's prescription duly prioritised based on health parameters?,Remdesivir.... You are in the queue  SARS-CoV2 Virus.... For sure  Such a huge crowd during deadly Pandemic! Why shouldn't Cipla Distributor or State Government agency just deliver the stuff to hospital based on doctor's prescription duly prioritised based on health parameters?,Good nos from cipla and Aditya Birla Capital.,@nikhil_daware @ZydusUniverse @CPMumbaiPolice @MumbaiPolice @Cipla_Global Thank you for contacting #DilKiPolice. Please lodge your grievances at  https://t.co/UX8RcXyvXF or e-mail us on acp-cybercell1@delhipolice.gov.in so that needful can be done. Guidance is available on helpline numbers 155260 and 01123469900.,""You got the prioritisation right, but you‚Äôre in a crisis on allocation.""  Murali Neelakantan (@grumpeoldman), former global general counsel at Cipla and Dr. Ashish Kulkarni (@ashish2727) from Gokhale Institute in conversation with Scroll's @RohanV.    https://t.co/gHtCdlPy8c,#Cipla on Friday posted 73 per cent rise in consolidated net profit at Rs 412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets  #PharmaCompanies #Earnings #Q4results #Pharma  https://t.co/IAfkQ98B3S,The director-choreographer posted the video on Instagram with the hashtag #ciplakaremodsouza (‚ÄòCipla‚Äôs Remo D‚ÄôSouza‚Äô).   https://t.co/q487tAUcst,Cipla‚Äôs Q4 net profit surges 73% to ‚Çπ412 crore  https://t.co/EtJ9AZ9VX7,Cipla‚Äôs quarterly profit fell, missing estimates. #Q4WithBQ  https://t.co/gezvNXoeGv"
2021-05-16,,,,,,"#Cipla posted decent numbers,with Profit up 7% at 412Cr,Revenue up 5% at 4606Cr,Ebitda up 26%&amp;Margins up 280bps at 17.3%  Infra giant L&amp;T too saw robust results,with Consol Profit up 11% at 3820Cr  Revenue of L&amp;T,up 9% at 48088Cr  Ebitda up 25%&amp;Margins up 170bps at 13.3% #Economy,Consider it done ‚úÖ   special thanks to @rajeevv03960221 @wordsbyshweta and Cipla @SoodFoundation üáÆüá≥,ICICI sec says cipla results miss but focus remains intact. Upgrades to 1040 rs from 975 rs.,Cipla says supply of COVID-19 drug remdesivir catching up with demand #ETIndustryNews  https://t.co/BAYPUCOrty,Cipla says supply of Covid-19 drug #Remdesivir catching up with demand   https://t.co/TFwUE6pYFB,India's Cipla (CIPL.NS) said on Saturday that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with demand after the company sought to boost production amid a massive second wave of coronavirus infections in the country.‚Äã  https://t.co/Ajl2sXNTK2"
2021-05-17,881.2000122070312,895.0,905.0,870.0,14122085.0,"The OI of CIPLA 880 May 27 Call option stood strong, 123.7% up, a change of 186550 from its previous value.,üì¢F&amp;O: Today‚Äôs Update (May 17, 2021)  Cipla share price was down by 3%+ after it's Q4 earnings missed expectations, finally closing it‚Äôs price at Rs. 883 at market close.,You need to ask hospital to write an email to Cipla company and then you can contact @tehseenp he may do the needful.,@Brahmachaaari @arjunbhatigolf No bureaucracy. Stocks came today.  Approval has been given but Novacare hadn't got it. I've spoken to Cipla &amp; got it sent across to the Distributor. Pharmacist from hospital has moved to dealer simultaneously. Talked to Juhi many times. Let's hope that the Tocilizumab helps.  https://t.co/jmJnhYJgVd,@swarjeeta OK, Sonali. Approval has been given but the stocks weren't available with the distributor. I have spoken to Cipla and got it sent across to the dealer. Pharmacist from hospital has moved to dealer simultaneously. Talked to Juhi many times. Let's hope that  Tocilizumab helps.  https://t.co/QcLFbBywGQ,Many Congratulations Team @ibreathefree &amp; #Schbang for winning the prestigious title at #KaleidoAwards 2021. Here's a message from @shrishail_, Head - Consumer Marketing and Breathefree, @Cipla_Global, that will surely inspire many others.   Winners List -  https://t.co/6s5sXQxxnK  https://t.co/LuXtsY92WC,Closing Bell: Indices end higher; Sensex shoots over 800 pts; Nifty above 14,900 levels. Gainers: IndusInd Bank (+7%), SBI (+6%), ICICI Bank (+4%). Losers: Cipla, Bharti Airtel (-2%).   https://t.co/NfweYNmT4X #StockMarket #stocks #Nifty,Nifty Pharma index under pressure; Cipla tanks ~3%; Torrent Pharma leads  https://t.co/LGYKE0lClb #nifty #niftypharma #sensex #StocksToWatch #stockmarkets #stocks #cipla #torrentpharma,Earlier, #EliLilly had announced signing of six voluntary license agreements with #Cipla, #Lupin, #SunPharma, #DRreddys, #MSNLaboratories and #TorrentPharmaceuticals.  https://t.co/BuXNFxNi14,Neutral on Cipla, target price Rs 840:  Motilal Oswal #ETMarkets #DailyRecos #StockPicks #DailyPicks  https://t.co/yQFGTknXsI,The share price of #Cipla fell nearly 4 percent on Monday after the firm's earnings missed analysts' estimates on all parameters in the March quarter. #Q4Earning #Earnings  https://t.co/UC1LvVlKrk,Stocks to track in trade for May 17, 2021: L&amp;T, Oberoi Realty, Cipla, Indigo Paints, Trident.   https://t.co/Xm4ElKV2vf,#MCPro: @Cipla_Global is redrawing its strategy in light of the second wave. Two factors here give investors a lot to look forward to. (via @anubhavsays)   #Cipla #COVID19 #Business    https://t.co/6dU7st5hZ6,Cipla posts 68% yoy rise in Q4 PAT to Rs413cr; US biz reports revenue of $138M  https://t.co/W1E7mk1lKw #cipla,Didn‚Äôt knew Cipla made one more vaccine for Covid-19 ü§£ #ciplakaremodsouza  https://t.co/xyJlbe4Lct,Cipla's stock fell more than 3% in morning trades on Monday, as the drug manufacturer disappointed posting a weaker than expected Q4 performance, with a tepid 4% year-on-year growth on the domestic front   https://t.co/2827Dhs7BN,The company's performance in Q4FY21 was weighed by moderate YoY growth in India Domestic Formulation (DF)/South Africa and decline in API sales for the quarter  #Cipla #StockMarket #Stocks #StocksToWatch #StockMarketTrading #MarketsWithBS  https://t.co/nkWOvn0AVS,Cipla share price falls 3% post Q4 earnings. Here's what brokerages expect   https://t.co/mQmKskfDqH  https://t.co/KMtUUkSOpu,The company already makes and markets antiviral drugs like #remdesivir, #favipiravir in India apart from importing and distributing Roche's #tocilizumab (Actemra)  @sohinidastweets reports  #PharmaCompany #Coronavirus #Cipla #CoronavirusVaccination   https://t.co/7OEXIIIYm6,Opening Bell: Market opens on a positive note; Sensex rises over 250 pts; Nifty above 14,700 levels. Gainers: ITC (+2%), UPL, L&amp;T, ONGC (+1%). Losers: Tata Steel, JSW Steel, Cipla (-1%).  https://t.co/NfweYNmT4X #StockMarket #stocks #Nifty #StocksToWatch,#StocksInFocus on May 17: #L&amp;T, #Cipla, #BalkrishnaIndustries, #Cheviot to #AdaniGreen; here are expected 5 Newsmakers of the Day #PaisaKaiseBanae @AnilSinghvi_   https://t.co/del6dDT0Xn,#StocksToWatch | Here are top stocks that could be in focus today!  üëâ Adani Green Energy üëâ Cipla üëâ Bharti Airtel   https://t.co/o9dIPI9y4E,#SharekhanFNA #SharekhanResearch retains Buy rating on #Cipla (PT Rs1100) #Q4FY21 was a strong quarter on YoY basis but results missed estimates; Covid led prospects to drive India business, Q1Fy22 likely to strong qtr for India, ramp up in gAlbuterol to fuel the US growth,Nifty may trade in 14,400-15,000 range this week, Bank Nifty below 20, 50, 100 day SMAs; Wipro, Cipla in focus #Nifty #NiftyBank #Lupin #StockMarket #StocksInNews   https://t.co/xyMB254Q5R,‡§ú‡§æ‡§®‡§ø‡§è @SumitResearch ‡§∏‡•á #Cipla ‡§™‡§∞ #TheBigBrokerageReport  #AwaazMarkets #Q4WithAwaaz  https://t.co/NFbj5uGMwx,#morning India @MotilalOswalLtd #StocksToWatch  #DRreddys #Cipla weak Q4 nos üëé  #Hester in talks with Bharat biotech to produce #Covaxin via tech trf. #zensar M3bi acquisition to help scale to BFSI  AB Capital strong Q4 nos Muthoot fin - firm gold prices üëç #Nifty #stocks,#GoodBadUgly‡•§ ‡§â‡§Æ‡•ç‡§Æ‡•Ä‡§¶‡•ã‡§Ç ‡§™‡§∞ ‡§ñ‡§∞‡•á ‡§®‡§π‡•Ä‡§Ç ‡§â‡§§‡§∞‡•á #CIPLA ‡§ï‡•á ‡§ö‡•å‡§•‡•á ‡§§‡§ø‡§Æ‡§æ‡§π‡•Ä ‡§ï‡•á ‡§®‡§§‡•Ä‡§ú‡•á,  ‡§Ö‡§®‡•Å‡§Æ‡§æ‡§® ‡§∏‡•á ‡§ï‡§Æ‡§ú‡•ã‡§∞ ‡§∞‡§π‡§æ REVENUE, MARGIN ‡§î‡§∞ ‡§Æ‡•Å‡§®‡§æ‡§´‡§æ, Generic ‡§¶‡§µ‡§æ‡§ì‡§Ç ‡§∏‡•á ‡§¨‡§¢‡§º‡•Ä ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§ï‡•Ä ‡§ï‡§Æ‡§æ‡§à  @AEHarshada #Q4WithAwaaz  https://t.co/g1UXOmqK9p,#BhartiAirtel, #Cipla, #SBI, Gland Pharma, Tata Motors, L&amp;T, Jindal Stainless #stocks in focus  #stockmarkets #SGXnifty  https://t.co/xFRufGkhst,Top stocks in focus: Hero MotoCorp, Cipla, Larsen &amp; Toubro, IDBI Bank, Bharti Airtel  https://t.co/NIhvL9061q #Nifty #sensex #stockmarkets #StocksInNews #stocks #heromotocorp #cipla #idbibank #bhartiairtel,L&amp;T and #Cipla are among the top stocks to watch out for today. Here's the full list: #StockMarket #StocksToWatch #StocksInNews    https://t.co/EojlfhzNcn,#4QWithCNBCTV18 | Morgan Stanley has an Overweight call on Cipla with a target of Rs 949/sh  https://t.co/utuqJNE4MK,#ComingUp‡•§ ‡§ó‡•ç‡§≤‡•ã‡§¨‡§≤ ‡§∏‡§Ç‡§ï‡•á‡§§ ‡§¨‡•á‡§π‡§§‡§∞‡•§ ‡§¨‡§æ‡§ú‡§æ‡§∞ ‡§Æ‡•á‡§Ç ‡§¶‡§ø‡§ñ‡•á‡§ó‡§æ ‡§ñ‡§∞‡•Ä‡§¶‡§æ‡§∞‡•Ä ‡§ï‡§æ ‡§ú‡•ã‡§∂! ‡§®‡§§‡•Ä‡§ú‡•ã‡§Ç ‡§ï‡•á ‡§¨‡§æ‡§¶ L&amp;T , CIPLA ‡§Æ‡•á‡§Ç ‡§∏‡•ç‡§ü‡•ç‡§∞‡•à‡§ü‡•á‡§ú‡•Ä ‡•§ ‡§ú‡§æ‡§®‡§ø‡§è ‡§¨‡§æ‡§ú‡§æ‡§∞ ‡§™‡§∞ ‡§∂‡•à‡§≤‡•á‡§Ç‡§¶‡•ç‡§∞ ‡§≠‡§ü‡§®‡§æ‡§ó‡§∞ ‡§ï‡§æ ‡§®‡§ú‡§∞‡§ø‡§Ø‡§æ ‡•§ ‡§µ‡•Ä‡§∞‡•á‡§Ç‡§¶‡•ç‡§∞ ‡§ï‡•Ä ‡§∏‡§ü‡•Ä‡§ï INDEX ‡§∏‡•ç‡§ü‡•ç‡§∞‡•à‡§ü‡•á‡§ú‡•Ä‡•§ ‡§¶‡•á‡§ñ‡§ø‡§è #‡§Æ‡•Å‡§®‡§æ‡§´‡•á_‡§ï‡•Ä_‡§§‡•à‡§Ø‡§æ‡§∞‡•Ä ‡§Æ‡•á‡§Ç @shail_bhatnagar, ‡§î‡§∞ @virendraonNifty ‡§ï‡•á ‡§∏‡§æ‡§•‡•§  https://t.co/Gv5OsLhTEB,#4QWithCNBCTV18 | Goldman Sachs maintains Neutral call on Cipla after co misses its estimates in Q4  https://t.co/5ZVQxc5RML,#4QWithCNBCTV18 | JPMorgan has a Neutral call on Cipla as US biz &amp; margin disappoint  https://t.co/CjlNE0GsqB,#BrokerageRadar | Check out the top brokerage views, before starting your trading day  @asianpaints @drreddys @cipla_global  #MarketsWithETNOW  https://t.co/eT5bY2YO2Y,CLSA on CIPLA BUY TP Rs1080 from Rs1020 Weak quarter despite adjustments Covid-19 products &amp; monetisation of US inhaler pipeline key catalysts Weak qtr with a miss across sales, Ebitda &amp; net profit Growth was rather muted across geographies Raise 22-23CL EPS by 2-3% @ekta_batra"
2021-05-18,884.4000244140625,887.0,888.3499755859375,878.4500122070312,5129966.0,"Acordo firmado pelo TRT-SC vai beneficiar cerca de 650 ex-empregados do Grupo Cipla  https://t.co/Zpox9izXa8  https://t.co/EscYUcQykB,Urgent request for help for a critical patient - Name - C Arul Pillai (male) Location:Ahmedabad Age: 54 Need - Tociliozubam injection (Cipla) Hospital - CIMS, Ahmedabad Contact - Krunal Pillai, 08866507497 @Suhelseth @sanjayraina @priyankac19 @AdityaRajKaul @hussain_imtiyaz,Required injection:- Ambisome by Mylan pharma Or Abhope by Abbott Or Phosome by Cipla. Dose: 250 mg / day x 7 days  Patient name : Raghav Bindal Place : Delhi Attendant name:Gautam(9810292200) #BlackFungus #sos #delhi,India will remain as a powerhouse of generic drugs and vaccines, says Umang Vohra, MD &amp; Global CEO, Cipla.  https://t.co/M1duJZ3U57,Please ask hospital to write an email to Cipla company and share the screen shot with me will do the needful. This injection not available outside.,#CovidWarriors ‡•§ Generics ‡§¨‡§ø‡§ú‡§®‡•á‡§∏ ‡§™‡§∞ ‡§´‡•ã‡§ï‡§∏ ‡§¨‡§¢‡§º‡§æ‡§Ø‡§æ‡•§ USFDA ‡§ï‡•á ‡§∏‡§æ‡§• ‡§Æ‡§ø‡§≤‡§ï‡§∞ Advair ‡§ú‡•á‡§®‡§∞‡§ø‡§ï ‡§™‡§∞ ‡§ï‡§æ‡§Æ‡•§ Remdesivir ‡§ï‡•Ä ‡§∏‡§™‡•ç‡§≤‡§æ‡§à ‡§¨‡§¢‡§º‡§æ‡§à‡•§ ‡§Ø‡§π ‡§ï‡§π‡§®‡§æ ‡§π‡•à @Cipla_Global ‡§ï‡•á MD &amp; Global Ceo #UmangVohra ‡§ï‡§æ ‡•§ Cipla ‡§ï‡•á ‡§®‡§§‡•Ä‡§ú‡•á ‡§î‡§∞ ‡§Ü‡§ó‡•á ‡§ï‡•Ä ‡§Ø‡•ã‡§ú‡§®‡§æ‡§è‡§Ç ‡§™‡§∞ ‡§¨‡§æ‡§§‡•Ä ‡§ï‡•Ä @AEHarshada ‡§®‡•á‡•§   #AwaazMarkets #MidcapMantra  https://t.co/ODCeMBCHJj,Sistema previdenziale, in Commissione #EntiGestori audizione, in videoconferenza, dei patronati Cepa, Cipla, Cipas e Copas. Diretta:  https://t.co/7HqvLhjFmx #OpenCamera #OpenParlamento  https://t.co/YrxxAmH02E,Umang Vohra of Cipla feels there is a need to create stockpile of COVID drugs along with rapid #vaccination to tackle the spread of the virus. Listen in.  @Vohra_Umang @Cipla_Global #TheMarket #EarningsWithETNOW  https://t.co/TWVTDsYEP3,One #rawmaterial that is used in #Remdesivir is seeing a shortage globally, says Umang Vohra of Cipla. Is this a concern? Listen in  @Vohra_Umang @Cipla_Global #COVIDSecondWave #EarningsWithETNOW  https://t.co/M6KPsLFXM9,‡§∞‡•á‡§Æ‡§°‡•á‡§∏‡§ø‡§µ‡§ø‡§∞ ‡§â‡§§‡•ç‡§™‡§æ‡§¶‡§® ‡§ï‡•Ä ‡§ï‡•ç‡§∑‡§Æ‡§§‡§æ 5 ‡§ó‡•Å‡§®‡§æ ‡§¨‡§¢‡§º‡§æ‡§à: ‡§ï‡•á‡§¶‡§æ‡§∞ ‡§â‡§™‡§æ‡§ß‡•ç‡§Ø‡•á, ‡§ó‡•ç‡§≤‡•ã‡§¨‡§≤ CFO, ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ  #CorporateRadar #Cipla @SwatiKJain @Cipla_Global  https://t.co/IMjNWoPI7T,Remdesivir to the rescue of Cipla‚Äôs languishing earnings!  https://t.co/2zOcw9V86J,#TheMarket | Digital adaptions here to stay; margins will see an uptick, says Umang Vohra of Cipla.   @Vohra_Umang @Cipla_Global #digital #COVIDSecondWave #EarningsWithETNOW  https://t.co/TFaN3bf3N4,‡§ï‡•â‡§∞‡§™‡•ã‡§∞‡•á‡§ü ‡§î‡§∞ ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ  ‡§Ü‡§ú ‡§¶‡•á‡§ñ‡§ø‡§è ‡§®‡§§‡•Ä‡§ú‡•ã‡§Ç ‡§™‡§∞ ‡§∏‡•ã‡§®‡§æ‡§ü‡§æ ‡§∏‡•â‡§´‡•ç‡§ü‡§µ‡•á‡§Ø‡§∞ ‡§ï‡•á CFO ‡§ú‡§ó‡§®‡•ç‡§®‡§æ‡§• ‡§ö‡§ï‡•ç‡§∞‡§µ‡§∞‡•ç‡§§‡•Ä ‡§î‡§∞ ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡•á ‡§ó‡•ç‡§≤‡•ã‡§¨‡§≤ CFO ‡§ï‡•á‡§¶‡§æ‡§∞ ‡§â‡§™‡§æ‡§ß‡•ç‡§Ø‡•á ‡§ï‡•á ‡§∏‡§æ‡§• ‡§ñ‡§æ‡§∏ ‡§¨‡§æ‡§§‡§ö‡•Ä‡§§ 12 PM ‡§™‡§∞  #CorporateRadar #SonataSoftware #Cipla @SwatiKJain @Sonata_Software @Cipla_Global  https://t.co/s1G8ISYiql,#TheMarket | Umang Vohra of Cipla doesn't think #Remdesivir supply will be a cause of concern going ahead. Here's why  @Vohra_Umang @Cipla_Global #COVIDSecondWave #EarningsWithETNOW  https://t.co/v5yoEXiLSz,Willing to partner with global  majors to import vaccines. We can repurpose facilities for fill &amp; finish of vaccines if required, says Umang Vohra of @Cipla_Global  https://t.co/HJiPyvEFak,#TheMarket | Umang Vohra of Cipla believes #India will continue to retain its position as powerhouse of generic drugs  @Vohra_Umang @Cipla_Global #COVIDSecondWave #EarningsWithETNOW  https://t.co/20TqOPoifu,#TheMarket | Umang Vohra of Cipla on how to prepare for the next COVID wave.     @Vohra_Umang @Cipla_Global #COVIDSecondWave #EarningsWithETNOW  https://t.co/KUXfCQj7U9,#4QWithCNBCTV18 | Cipla‚Äôs Q4 earnings missed estimates. MD &amp; CEO of @Cipla_Global, @Vohra_Umang says the co will see biz growth in FY22. Tells @latha_venkatesh, @_soniashenoy &amp; @SurabhiUpadhyay that he expects input price rise to abate, based on demand-supply easing. (2/2)  https://t.co/jzgTb1CrqH,#4QWithCNBCTV18 | Cipla‚Äôs Q4 earnings missed estimates. MD &amp; CEO of @Cipla_Global, @Vohra_Umang says the co will see biz growth in FY22. Tells @latha_venkatesh, @_soniashenoy &amp; @SurabhiUpadhyay that he expects input price rise to abate, based on demand-supply easing. (1/2)  https://t.co/7bzcRckWF3,#LIVE | Watch Umang Vohra of Cipla on Q4 earnings and COVID portfolio.     @Vohra_Umang @Cipla_Global #TheMarket #EarningsWithETNOW  https://t.co/M8TetkdprV,Talking Point | Cipla failed to impress the street. Will new launches change the picture in FY22? @_nirajshah in conversation with CFO Kedar Upadhye. #Q4WithBQ #BQLive  https://t.co/TO290FYF10,Reading- almost all broking houses upgrade cipla. Source- Bloomberg and ET  https://t.co/wieDtPSEy7,#CIPLA within 5% of 50-day moving average. #BuyingOpportunity #TradingOpportunity ?  https://t.co/nVDNP8T7KR  https://t.co/zHOqJIPta6,#TheMarket | Catch Umang Vohra of Cipla at 9:30 am, only on ET NOW.  @Vohra_Umang @Cipla_Global #EarningsWithETNOW  https://t.co/0dKSGCMs2H"
2021-05-19,903.9500122070312,887.8499755859375,905.9500122070312,881.0,7242643.0,"Please help @Rajasthan_PYC @GaneshGINC #SOSRPYC  Need urgent Tocilizumb cipla 400mg Patient name: Gaurav Yadav Age: 41 SPO 2 with support 87-90 During lunch time when he shifts to Nozzle based supply it's 78-79 Contact: 9953224714 Hospital- TB Sanatorium, Jaipur,Ask the other companies to start helplines as well. Cipla did last year. And @BioconBiologics is running one this year.  What do you think @malini_aisola? Would this help or is the situation completely beyond these ideas now?,Mehra: Central Government can seek instructions on this and can come back on it tomorrow. Not only Delhi but states all over want this Medicine.  Court: Is it manufactured in India?  Court is informed that manufacturers including Cipla manufactures the said medicine.,@catterone @COVIDNewsByMIB @CovidIndiaSeva @CovRelief @COVResourcesIn @Cipla_Global @BharatBiotech @myogiadityanath @dm_ghaziabad @iitdelhi @PMOIndia ‡§ï‡•É‡§™‡§Ø‡§æ ‡§Ö‡§®‡•Å‡§∞‡•ã‡§ß ‡§π‡•à ‡§ï‡§ø ‡§Ü‡§™ ‡§ú‡§®‡§™‡§¶ ‡§ï‡•Ä ‡§π‡•á‡§≤‡•ç‡§™‡§≤‡§æ‡§á‡§® ‡§®0- 0120-2965758, 0120-2829040, 0120-2965798, 0120-2965799, 0120-2965757, 0120-4186453, 9910426374, 8826797248 ‡§™‡§∞ ‡§∏‡§Ç‡§™‡§∞‡•ç‡§ï ‡§ï‡§∞‡•á‡§Ç ‡§Ü‡§™‡§ï‡•Ä ‡§π‡§∞ ‡§∏‡§Æ‡•ç‡§≠‡§µ ‡§Æ‡§¶‡§¶ ‡§ï‡•Ä ‡§ú‡§æ‡§è‡§ó‡•Ä‡•§ ‡§™‡•Å‡§≤‡§ø‡§∏ ‡§∏‡§π‡§æ‡§Ø‡§§‡§æ ‡§π‡•á‡§§‡•Å 112 ‡§®‡§Ç‡§¨‡§∞ ‡§°‡§æ‡§Ø‡§≤ ‡§ï‡§∞‡•á‡§Ç |,Pain is the body's signal that it needs extra care. Dr Ramona Govender tells us how to fix what hurts on #HealthMatters, a podcast by @CiplaRSA. Listen at  https://t.co/hzij5WRGWG or  https://t.co/34qAaqGUuQ #Cipla #HealthMatters"
2021-05-20,924.2000122070312,906.0,927.9000244140624,905.0,12378690.0,"@foot_loose_apra @Namrata_Joshi There is a central govt order that Remdesvir is to be only procured by hospitals, not individuals. My suggestion is to check the Biocon and Cipla helplines. Both forms sell Remdesvir. Ask what to do there. @BioconBiologics,#RTPCR  #COVID19India  Cipla To Launch RT-PCR Test Kit ‚ÄòViraGen‚Äô In India Partnership With Ubio Biotech  https://t.co/Cyq2ZHwa9Q,Sachin Katiyar just got an upGrad.   He was working as a System Analyst with NSE. After completing his MS in Data Science, he has been placed in CIPLA - a renowned pharmaceutical company, as a Lead Data Scientist.   #KaamKiDegree #LifeLongLearning  https://t.co/vklY7EPoM8,‡§¶‡§ø‡§ó‡•ç‡§ó‡§ú ‡§¶‡§µ‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ (Cipla) ‡§Ö‡§¨ ‡§ï‡•ã‡§µ‡§ø‡§°-19 ‡§ï‡•Ä ‡§ú‡§æ‡§Ç‡§ö ‡§ï‡•á ‡§≤‡§ø‡§è ‡§è‡§ï ‡§®‡§à¬†RT-PCR ‡§ï‡§ø‡§ü 'ViraGen' ‡§≤‡§æ ‡§∞‡§π‡•Ä ‡§π‡•à    https://t.co/JPBkQ2fFPf,This injection is not available outside, your hospital needs to send a request email to cipla company and then you can send me the scan copy of email will ask @tehseenp to do the needful immediately thank you.,Cipla, M&amp;M and BPCL were among the top gainers in #Nifty50 while Tata Steel, Hindalco and Coal India were among the top losers. #Sensex #stockmarkets   https://t.co/7ZppX2Ggx9,Markets close bearish; Sensex sheds 340 pts, Nifty 50 holds 14,920; Metal nosedives; M&amp;M, Cipla top bulls  https://t.co/Y0jNbuXrr2 #sensex #nifty #NIFTYMETAL #StockMarket #StocksToWatch #stocks #cipla,#MarketAtClose | M&amp;M, Cipla, BPCL, IndusInd, Titan gain in a weak trading session. Britannia slips 3% on concerns w.r.t related party transactions. IOC falls over 2% despite reporting a strong set of earnings for Q4.  https://t.co/bh3uWRPOA6,COVID: Cipla launches 'ViraGen' RT-PCR test   https://t.co/hWwuqKoLJu  #cipla #RTPCR #CoronavirusIndia,Closing Bell: Markets end lower for second day; Nifty ends below 15K; Nifty Metal slips 3%. Losers: Tata Steel (-4.90%), Hindalco (-4.5%), Coal India (-3.29%). Gainers: M&amp;M (+2.48%), Cipla (+2.26%), BPCL (+1.99%).  https://t.co/nP8IoIja67 #StockMarket #NiftyMetals #Nifty,#Cipla Limited on Thursday announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‚ÄòViraGen for #COVID19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd.  https://t.co/78gTX93gct,Drug major Cipla announced the commercialisation of its RT-PCR test kit ‚ÄòViraGen‚Äô for #COVID19 in India, in partnership with Ubio Biotechnology Systems.  https://t.co/hHpbuqHOJc,Cipla Launches Covid-19 Detection Test Kit ; Shares Gain   https://t.co/S7F8HJvgd9,Cipla launches RT-PCR test kit 'ViraGen' in India partnership with Ubio Biotech #ETIndustryNews  https://t.co/sQRRYvsYkt,#Cipla launches RT-PCR test kit ‚ÄòViraGen‚Äô in India partnership with Ubio Biotech   https://t.co/AAxGqis7CU #ExpressBiz,‡§¶‡§ø‡§ó‡•ç‡§ó‡§ú ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ‡§®‡§Ç ‡§Ü‡§™‡§≤‡§Ç ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§µ‡§ø‡§∑‡§æ‡§£‡•Ç‡§ö‡•ç‡§Ø‡§æ ‡§ö‡§æ‡§ö‡§£‡•Ä‡§∏‡§æ‡§†‡•Ä ‡§Ü‡§µ‡§∂‡•ç‡§Ø‡§ï ‡§Ö‡§∏‡§≤‡•á‡§≤‡§Ç ‡§ü‡•á‡§∏‡•ç‡§ü‡§ø‡§Ç‡§ó ‡§ï‡•Ä‡§ü ‡§≤‡§æ‡§Å‡§ö ‡§ï‡•á‡§≤‡§Ç ‡§Ü‡§π‡•á.  #CoronavirusIndia #cipla #India #coronatestingkit   https://t.co/lPFfJ5xbim,‡≤≠‡≤æ‡≤∞‡≤§‡≤¶ Bharat Serum Institute, Sun Pharma,Nylon, Cipla,Gufic Celon ‡≤ï‡≤Ç‡≤™‡≤®‡≤ø‡≤ó‡≤≥‡≥Å ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤µ‡≤ø‡≤¶‡≥á‡≤∂‡≤¶ Swiss Parenterals (Switzerland),Aspen (Australia), Abbott laboratories(USA), Arkopharma(USA) ‡≤ï‡≤Ç‡≤™‡≤®‡≤ø‡≤ó‡≤≥‡≥Å ‡≤ï‡≤™‡≥ç‡≤™‡≥Å ‡≤∂‡≤ø‡≤≤‡≥Ä‡≤Ç‡≤ß‡≥ç‡≤∞ ‡≤∞‡≥ã‡≤ó‡≤ï‡≥ç‡≤ï‡≥Ü ‡≤î‡≤∑‡≤ß ‡≤§‡≤Ø‡≤æ‡≤∞‡≤ø‡≤∏‡≥Å‡≤§‡≥ç‡≤§‡≤µ‡≥Ü. ‡≤à ‡≤ï‡≤Ç‡≤™‡≤®‡≤ø‡≤ó‡≤≥‡≤ø‡≤Ç‡≤¶ ‡≤∏‡≤∞‡≥ç‡≤ï‡≤æ‡≤∞ ‡≤ï‡≥Ç‡≤°‡≤≤‡≥á ‡≤î‡≤∑‡≤ß ‡≤§‡≤∞‡≤ø‡≤∏‡≤ø‡≤ï‡≥ä‡≤≥‡≥ç‡≤≥‡≤¨‡≥á‡≤ï‡≥Å. 5/5,Cipla has launched a new Covid-19 RT-PCR Test Kit ‚ÄòViraGen.‚Äô   https://t.co/QmKNhpVUzU,CJ Chauhan: Has any action been taken against #CIPLA for failing to supply an adequate amount of #remdesivirinjection (as per the contract)?  State: We have put pressure on #CIPLA, and asked them to supply otherwise we will take action. Sir, even they are working under pressure.,CJ now quizzing on what action can be taken if supply of #Remdesivir by manufacturers falls short &amp; who can take action, whether State or Centre?  Centre will take action if CIPLA defaults, Ved Prakash Mishra submits  He adds that action was taken earlier when CIPLA made defaults,Cipla shares are on a three-session gaining streak.    https://t.co/Ue3TwKtWQf,COVID-19: Cipla launches RT-PCR test kit 'ViraGen' in India partnership with Ubio Biotech  https://t.co/bZ49R9zF3h,#Cipla's #ViraGen is a real-time detection kit approved by the #ICMR (Indian Council of Medical Research). #rtpcrtest   https://t.co/ItDZAbcxwU,Drug major #Cipla announced the commercialisation of its RT-PCR test kit ‚ÄòViraGen‚Äô for #COVID19 in India, in partnership with Ubio Biotechnology Systems   https://t.co/6TBRv20351,Cipla launches #COVID19 real-time test kit 'ViraGen'; to be sold from May 25  https://t.co/82X3o9wg47,Cipla bounces back. In fact now higher than rest day. To me many favourable developments in co underway. üòä,Cipla with Ubio Biotechnology launches ‚ÄòViraGen‚Äô a polymerase chain reaction (RT-PCR) test for Covid  https://t.co/49iAY7wYGn #cipla,Cipla launches polymerase chain reaction test kit ‚ÄòViraGen‚Äô for #Covid19   https://t.co/333kHsGHSX  https://t.co/WArGcmAyFO,#COVIDSecondWave | Cipla introduces ‚ÄòViragen‚Äô #RTPCR test for #COVID19; says RT-PCR test kit in tie-up with Ubio Biotechnology (Agencies)  @ubiotec @cipla_global #Covid19IndiaHelp  https://t.co/rdKbnpzQaP,#JustIn | @Cipla_Global launches 'ViraGen', its third offering in the #COVID19 testing segment  https://t.co/AKfwWgoC7R"
2021-05-21,926.9000244140624,930.0,935.0,922.2999877929688,6740711.0,"@reachme_vamshi @Humanistplanet @mmanishbhargav @CiplaFoundation @tehseenp @julienpotet @Cipla_Global @RumanaHamied @JyoshnaDamma I have spoken to Principal Secretary, Health, Government of Andhra Pradesh. Will revert in some time after seeing their policy. 17 Govt Hospitals have been empanelled so far in the State for treatment of #Mucormycosis (Black Fungus),@anandmahindra I think Cipla is working on introducing it,See #TOPCALLS on @CNBC_Awaaz @CNBCBajar   BUY #Indiacement #infosys #cipla #MahMah #BPCL #CHOLAFIN   @tapariachandan @Rajesh_Satpute @rajeshpalviya @themanasjaiswal @PrakashGaba @AshishChatur  @mayureshm_joshi   @virendraonNifty  @BhumeetGupta,Cipla launches RT-PCR test kit ‚ÄòViraGen‚Äô in India, partnership with Ubio Biotech  https://t.co/34p8HGI5iO,Cipla will commence supply of the #COVID19 virus detection kit from May 25, 2021.   https://t.co/0w3zFRB3Bk"
2021-05-24,931.25,931.0,945.5,926.1500244140624,6420035.0,"Delhi : ‡§ï‡•ã‡§µ‡§ø‡§° ‡§ï‡•á ‡§á‡§≤‡§æ‡§ú ‡§Æ‡•á‡§Ç ‡§ï‡§æ‡§∞‡§ó‡§∞ Roche ‡§î‡§∞ Cipla ‡§ï‡•Ä ‡§è‡§Ç‡§ü‡•Ä‡§¨‡•â‡§°‡•Ä ‡§ï‡•â‡§ï‡§ü‡•á‡§≤ ‡§Ö‡§¨ ‡§≠‡§æ‡§∞‡§§ ‡§Æ‡•á‡§Ç ‡§≠‡•Ä ‡§â‡§™‡§≤‡§¨‡•ç‡§ß, ‡§è‡§Ç‡§ü‡•Ä‡§¨‡•â‡§°‡•Ä ‡§ï‡•â‡§ï‡§ü‡•á‡§≤ (Casirivimab ‡§î‡§∞ Imdevimab) ‡§ï‡•Ä ‡§™‡§π‡§≤‡•Ä ‡§ñ‡•á‡§™ ‡§≠‡§æ‡§∞‡§§ ‡§Æ‡•á‡§Ç ‡§â‡§™‡§≤‡§¨‡•ç‡§ß, ‡§è‡§ï ‡§°‡•ã‡§ú ‡§ï‡•Ä ‡§ï‡•Ä‡§Æ‡§§ 59,750 ‡§∞‡•Å‡§™‡§è ‡§π‡•à, ‡§è‡§ï ‡§ï‡§Ç‡§¨‡§æ‡§á‡§Ç‡§° ‡§°‡•ã‡§ú 1200 mg ‡§ï‡§æ ‡§π‡•à,Drug majors Roche India and Cipla on Monday announced launch of Roche's Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk  https://t.co/POLZmpzApP,Covid: Roche‚Äôs antibody cocktail launched in India, Cipla to market drug - Coronavirus Outbreak News  https://t.co/L4rvD4Mu1e,Roche's Antibody Cocktail Launched in India at Rs 59,750/Dose; Cipla to Market Drug in Country   https://t.co/FIj6NaRXt3  #antibodies #antibodycocktail #Cipla,#Roche, #Cipla launch #antibody cocktail #Casirivimab and #Imdevimab in India: Know price, function, benefits  #COVID19 #COVID19India #COVIDSecondWave    https://t.co/vHgjNMqn8o,#Roche India @Roche and #Cipla @Cipla_Global Limited have announced that the first batch of the Antibody Cocktail (#casirivimab and #Imdevimab)¬† Roche launches antibody cocktail to treat COVID-19, Cipla to market it pan-India  https://t.co/iw7WYRbm9p via @BioVoiceNews,#IndiaFightsCOVID | This antibody cocktail is recommended for anyone above the of 12 years old but needs to be atleast 40 kg of weight: V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India  @Roche India @Cipla_Global  https://t.co/2TcXx7K6kL,#IndiaFightsCOVID | The antibody cocktail will be available in the market from tomorrow or even today evening. The drug will be provided only to those who have a valid prescription: V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India.  @Cipla_Global @Roche  https://t.co/0p4Cy4VHsJ,#IndiaFightsCOVID | This antibody cocktail is recommended for anyone above the of 12 years old but needs to be atleast 40 kg of weight: V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India @Roche India @Cipla_Global   Watch #LIVE here -  https://t.co/RZHKU3wOei  https://t.co/IXNsmg6iDh,#IndiaFightsCOVID | We have adopted differential pricing in India. We have prized it in such a way that it is affordable to the Indian public: V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India @Roche @Cipla_Global   Watch #LIVE here -  https://t.co/RZHKU3wOei  https://t.co/Bi0MQlOUtX,#IndiaFightsCOVID | Once a person is detected with COVID, in mild to moderate cases, this antibody cocktail can be given. The timing is very important: V. Simpson Emmanuel, MD and CEO, Roche Pharma India  @Cipla_Global @Roche  Watch #LIVE here -  https://t.co/rGQJsiKgt2  https://t.co/5k4cbrQP37,#IndiaFightsCOVID | As Roche's antibody cocktail rolls out in India, V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India joins Republic TV in an exclusive interview.  @Cipla_Global @Roche  Watch #LIVE here -  https://t.co/rGQJsiKgt2  https://t.co/0cW3XhEKcC,#IndiaFightsCOVID | The antibody cocktail will be available in the market from tomorrow or even today evening. The drug will be provided only to those who have a valid prescription: V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India @Cipla_Global @Roche  https://t.co/MCRAW9iWvu,Cipla is saying you haven't placed any order : Singh  We've lifted every single vial : Mehra   #DelhiHighCourt,#IndiaFightsCOVID | Once a person is detected with COVID, in mild to moderate cases, this antibody cocktail can be given. The timing is very important: V. Simpson Emmanuel, MD and CEO, Roche Pharma India @Cipla_Global @Roche India  Watch #LIVE here -  https://t.co/RZHKU3wOei  https://t.co/EALULTNT4u,Maybe they can impress upon cipla to increase the supply : Mehra   I'm given to understand that it requires fermentation.. one enterprise does that. The other ingredient also has to be imported. There is a constraint in capacity and process : Rao   #DelhiHighCourt,#IndiaFightsCOVID | As Roche's antibody cocktail rolls out in India, V. Simpson Emmanuel, Managing Director and CEO, Roche Pharma India joins Republic TV in an exclusive interview. @Cipla_Global @Roche   Watch #LIVE here -  https://t.co/RZHKU3wOei  https://t.co/XZ4X6NHKFv,Mehra: They can ask Cipla to be proactive. It's only willing to produce 2000 more vials.  Rao: I am given to understand that the process involves fermentation process. There is 1 enterprise in India which does that. Other component needs to be imported.,Singh: There were orders placed by Cipla. Now to come up and say that we're responsible for the shortage, will take him neither here nor there.,We have filed the details. Mr Mehra will have to check this. The total case load for Delhi is about 200.. as far as I know, there were orders placed with Cipla.. to say we are responsible for shortage.. To blame us for everything is not correct: Singh   #DelhiHighCourt,Cipla launches Roche's Covid antibody cocktail in India for Rs 60,000 per dose  #Coronavirus @sohinidastweets   https://t.co/H7To5v03RW,Roche, Cipla launch antibody cocktail in India: Check price, availability and dose   https://t.co/Tg9MuDluC2 #CoronaVaccine,‡™ï‡´ã‡™∞‡´ã‡™®‡™æ‡™®‡™æ ‡™¶‡™∞‡´ç‡™¶‡´Ä‡™ì‡™®‡´Ä ‡™∏‡™æ‡™∞‡™µ‡™æ‡™∞‡™Æ‡™æ‡™Ç ‡™µ‡™™‡™∞‡™æ‡™§‡´Ä ‡™è‡™®‡´ç‡™ü‡´Ä‡™¨‡´ã‡™°‡´Ä ‡™ï‡´ã‡™ï‡™ü‡´á‡™≤ ‡™π‡™µ‡´á ‡™≠‡™æ‡™∞‡™§‡™Æ‡™æ‡™Ç ‡™â‡™™‡™≤‡™¨‡´ç‡™ß, ‡™ú‡™æ‡™£‡´ã ‡™∂‡´Å‡™Ç ‡™õ‡´á ‡™Ü ‡™¶‡™µ‡™æ‡™Æ‡™æ‡™Ç ‡™ñ‡™æ‡™∏ #cipla #roche #antibodycocktail #coronavirus #ZEE24KALAK    https://t.co/A6wOFsNpm3,@shrirambn @Somrita_Ghosh @khogensingh1 @richa_TNIE Drug majors #RocheIndia &amp; #Cipla has announced the launch of #Roche's Antibody Cocktail in India - priced at Rs 59,750 per dose - for treating mild to moderate #COVID19 in patients at high risk. Details üëá  https://t.co/eC2Dwjt0OS,‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§ï‡•á ‡§ñ‡§ø‡§≤‡§æ‡§´ ‡§¶‡•á‡§∂ ‡§Æ‡•á‡§Ç ‡§Ü‡§Ø‡§æ ‡§¶‡§µ‡§æ‡§ì‡§Ç ‡§ï‡§æ ‡§è‡§ï ‡§ï‡•â‡§ï‡§ü‡•á‡§≤, Roche ‡§µ Cipla ‡§®‡•á ‡§Æ‡§ø‡§≤‡§ï‡§∞ ‡§ï‡§ø‡§Ø‡§æ ‡§≤‡•â‡§®‡•ç‡§ö !  #CoronaVirus    https://t.co/EP6eaw5VQd,Cipla, Roche launch #covid19 antibody cocktail at ‚Çπ59,750 per dose  (@LeroyLeo7 reports)    https://t.co/gVIvMYvBBD  https://t.co/cVCHOFbQzc,Nifty Pharma holds steady amid slowdown in Covid resurge, vaccination progress; Cadila, Dr Reddy's, Cipla lead  https://t.co/ce2Mfd1CYx #nifty #niftypharma #sensex #StockMarket #StocksToBuy #stocks #cadila #DRreddys #cipla,.@Roche Covid antibody cocktail launched in India. Priced at Roche‚Äôs Rs 59,750 per patient, @Cipla_Global to market it. second batch to be available by mid-June. @XpressBengaluru @santwana99 @DHFWKA @NammaBengaluroo @MoHFW_INDIA @WeAreBangalore  https://t.co/vc0E39wSmv,Roche India and Cipla announced launch of Roche's Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate #COVID19 in patients who are at high risk. Follow LIVE Updates:  https://t.co/fp119Um1sG  https://t.co/4XcZ4DsCO1,#Roche's #AntibodyCocktail (Casirivimab and Imdevimab) for #COVID19 treatment is now available in India at a price of Rs 59,750 per dose. It will be marketed in the country by #Cipla.  https://t.co/IYCHrOOvch,Roche India on Monday announced the rollout of its first batch of the antibody cocktail (Casirivimab and Imdevimab) against #Coronavirus in #India. The cocktail drug will be marketed by Cipla pan-India.  https://t.co/omOhG9a7Ud,In a joint statement with Cipla, Roche India said that the second batch of the #Covid19 drug will be made available by mid-June.    https://t.co/5HIm3Xp481,Roche India &amp; Cipla launch the #COVID19 antibody cocktail Casirivimab &amp; Imdevimab in India. @viswanath_pilla with the latest details ‚§µÔ∏è  @rocheindia @Cipla_Global #Casirivimab #Imdevimab #Pharma    https://t.co/DZsK9UnCX7,The first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. #Cipla #Roche   https://t.co/nXzgq27j93,Roche‚Äôs Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India  https://t.co/Mk3aDLMwjY #roche,Roche‚Äôs Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India,#StocksInNews | Cipla: Starts selling in India @Roche's #antibody cocktail (Casirivimab &amp; Imdevimab); Second batch of antibody cocktail will be made available in #India by mid-June (Agencies)   @Cipla_Global #StocksToWatch #MarketsWithETNOW #Covid19IndiaHelp  https://t.co/CAitAGmsc0,‡™®‡´ç‡™Ø‡´Å‡™ù ‡™´‡´ç‡™≤‡´á‡™∂ : Cipla &amp; Roche ‡™è ‡™≠‡™æ‡™∞‡™§‡™Æ‡™æ‡™Ç ‡™§‡´á‡™Æ‡™®‡™æ ‡™∏‡™∞‡´ç‡™µ‡™™‡´ç‡™∞‡™•‡™Æ Antibody Cocktail ‡™¨‡´á‡™ö‡™®‡´Ä ‡™ú‡™æ‡™π‡´á‡™∞‡™æ‡™§ ‡™ï‡™∞‡´Ä,Roche's antibody cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India  https://t.co/PNl82BsQVK,@kb2227 @PMOIndia Yes it is partnered w Cipla."
2021-05-25,935.5999755859376,939.6500244140624,940.0,930.0,3695242.0,"Monoclonal Antibody therapy is now approved and available in both public and private hospitals across India. Thank you to @Cipla_Global @Roche for making this happen.   Please inquire about this med for you or a loved one  cc: @TwitterIndia @vikramchandra   https://t.co/wJoCWwPqkn,Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms  #India #CovidVaccines #VaccinationDrive #Moderna #Pfizer    https://t.co/UBoUBnJ72F,Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms.   https://t.co/Gf0dXlfqsm,Moderna in talks with Cipla, likely to launch single-dose Covid vaccine in India in 2022  Payal Banerjee @payaljourno and Prashant Rangnekar @prashant85 report   https://t.co/QEQVUmgxsI,Moderna in talks with Cipla, likely to launch single-dose Covid vaccine in India in 2022  Payal Banerjee @payaljourno and Prashant Rangnekar @prashant85 report   https://t.co/561nfL5HR7,@vaibhav83517742 @PiyushGoyal @Cipla_Global @srinivasiyc @CharuPragya @CMODelhi @tehseenp @BridgingTheGapF Not fair to tax paying citizens.,@vaibhav83517742 @PiyushGoyal @Cipla_Global @srinivasiyc @CharuPragya @CMODelhi @tehseenp @BridgingTheGapF And no one seems to know who has these vials and why doesn‚Äôt max Saket have them if approved?,#Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms    https://t.co/FOkg9ateXu,The Health Ministry has been asked to take an early decision on Cipla's request regarding support required by them for procurement of #Moderna vaccines.    https://t.co/mhY9Vuk08R,@vaibhav83517742 @PiyushGoyal @Cipla_Global @srinivasiyc @CharuPragya @CMODelhi @tehseenp @BridgingTheGapF pls help this person too. Desperately seeking amphotericin b,@HimansuAwasthi @Chaiti @PiyushGoyal @Cipla_Global @srinivasiyc @CharuPragya @CMODelhi Nopes. Can help with alternatives if doctors approve,#Cipla introduces #RTPCR test kit '#ViraGen' in Indian market: All you need to know  #COVID19 #COVIDEmergency #COVID19India    https://t.co/UMOVs6rYrs,@vaibhav83517742 @PiyushGoyal @Cipla_Global @srinivasiyc @CharuPragya @CMODelhi Where are the injections if centre has approved and sent to these hospitals? Why are patients not getting any? @tehseenp,Moderna expected to launch single-dose COVID-19 vaccine in India next year; talking to Cipla, other Indian firms to supply 5 cr doses: Sources,@Cipla_Global announces a new antibody cocktail to reduce the risk of hospitalisations and aid recovery of #COVID19 patients.,#COVID19India  Everything You Need To Know About Covid Antibody Cocktail Launched In India By Cipla  https://t.co/VDlJDcBnja,#ICYMI: Roche India &amp; Cipla launch the #COVID19 antibody cocktail Casirivimab &amp; Imdevimab in India.  @viswanath_pilla writes ‚§µÔ∏è   @rocheindia @Cipla_Global #Casirivimab #Imdevimab #Pharma    https://t.co/DZsK9UnCX7,ViraGen: Cipla Launches Real-Time COVID-19 RT-PCR Testing Kit; Here's All About The Testing Kit  #ViraGen #Cipla #RTPCR #COVID19 #Coronavirus @Cipla_Global   https://t.co/23GzQD992P,Cipla‚Äôs Covid-19 Testing Kit ‚ÄòViraGen‚Äô Will Hit The Market Today    https://t.co/0WSpM55OSU,Casirivimab and Imdevimab: Cipla, Roche launch antibody cocktail priced at Rs 59,750 per patient.   #casirivimab     https://t.co/OSEztnV2EM,‡¶≠‡¶æ‡¶∞‡¶§‡ßá ‡¶è‡¶á ‡¶ì‡¶∑‡ßÅ‡¶ß‡¶ü‡¶ø‡¶∞ ‡¶¨‡¶ø‡¶™‡¶£‡¶®‡ßá‡¶∞ ‡¶¶‡¶æ‡¶Ø‡¶º‡¶ø‡¶§‡ßç‡¶¨‡ßá ‡¶∏‡¶ø‡¶™‡¶≤‡¶æ (Cipla)‡ß∑ ‡¶™‡ßç‡¶∞‡¶•‡¶Æ ‡¶ß‡¶æ‡¶™‡ßá ‡¶è‡¶∏‡ßá‡¶õ‡ßá ‡¶è‡¶á ‡¶ì‡¶∑‡ßÅ‡¶ß ‡¶è‡¶¨‡¶Ç ‡¶¶‡ßç‡¶¨‡¶ø‡¶§‡ßÄ‡¶Ø‡¶º ‡¶ß‡¶æ‡¶™‡ßá ‡¶Ü‡¶∏‡¶¨‡ßá (mid-June) ‡¶ú‡ßÅ‡¶®‡ßá‡¶∞ ‡¶Æ‡¶æ‡¶ù‡¶æ‡¶Æ‡¶æ‡¶ù‡¶ø‡ß∑ #COVIDAntibodycocktail #coronavirus #India   https://t.co/g2CzxE7pQj,A real-time Covid-19 testing kit, launched last week by pharmaceutical major Cipla, will hit the markets today. Know about this testing kit, read here:   https://t.co/pYgYPYB5cd  https://t.co/D84HjtMC1c,#FAQ | Pharmaceutical companies #Cipla &amp; #Roche on 24 May, launched a coronavirus #antibody cocktail drug, which they claim is for non-hospitalised patients who face high risk of their infection turning severe. Here's what we know.  https://t.co/WATdl2oo2C,Let us try. Problem is Cipla has given all control to the Central government on Liposomal.  Central govt now decides which state gets how much! I believe Delhi got very few Liposomal despite a high request.  We need to now try and see if this can come to India via other countries,The Indian multinational pharmaceutical company Cipla‚Äôs real-time #COVID19 testing kit, #ViraGen which was launched last week, will be available in the market, the company said   https://t.co/1JytGF5Vb6,#EXCLUSIVE | Cipla's real-time COVID testing kit Viragen launched; know accuracy, procedure and prices here  #Viragen   https://t.co/yIERTR3YKh,Drug manufacturer #Roche #India on May 24, announced the launch of its first batch of #COVID19 antibody cocktail #Casirivimab &amp; #Imdevimab in India to treat mild to moderate covid patients. The price for each dose will be Rs 59,750 &amp; will be distributed in the country by #Cipla.  https://t.co/JHcufSjvAf,Roche in collaboration with Cipla launches their antibody cocktail for #COVID treatment. What do we know about it? We speak to @drbgee.  https://t.co/nhs1S2asaa,Roche India and  Cipla launch Antibody Cocktail Casirivimab and Imdevimab in India. These will help in the treatment of mild to moderate Covid-19 patients.  Read more details here:  https://t.co/56NfHkx2as  #Roche #Cipla #India #dailyhunt  https://t.co/dt8ymLYtOk,‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§ï‡•Ä '‡§è‡§Ç‡§ü‡•Ä‡§¨‡•â‡§°‡•Ä ‡§ï‡•â‡§ï‡§ü‡•á‡§≤' ‡§µ‡•à‡§ï‡•ç‡§∏‡•Ä‡§® ‡§ï‡•Ä ‡§≠‡§æ‡§∞‡§§ ‡§Æ‡•á‡§Ç ‡§è‡§Ç‡§ü‡•ç‡§∞‡•Ä, ‡§ü‡•ç‡§∞‡§Ç‡§™ ‡§ï‡•ã ‡§≠‡•Ä ‡§¶‡•Ä ‡§ó‡§à ‡§•‡•Ä ‡§Ø‡§π ‡§¶‡§µ‡§æ...‡§ú‡§æ‡§®‡§ø‡§è ‡§ï‡•Ä‡§Æ‡§§  https://t.co/D8SZs4eI9C  #PharmaceuticalcompanyRocheIndia #Cipla #AntibodyCocktail #DonaldTrump #US #FounderDoctorNareshTrehan #NationalNews #‡§¶‡§µ‡§æ‡§ï  https://t.co/XJVCZx6hvs,‡¶ï‡ßá ‡¶ï‡¶∞‡¶§‡ßá ‡¶™‡¶æ‡¶∞‡ßá ‡¶ü‡ßá‡¶∏‡ßç‡¶ü... #Cipla #coronavirus #CoronavirusIndia #COVIDEmergency #COVID19   https://t.co/IfQxxOVJnS,#GOODNEWS: #Corona ‡§ï‡§æ ‡§ü‡•á‡§∏‡•ç‡§ü ‡§ï‡§∞‡§®‡•á #cipla ‡§®‡•á ‡§Æ‡§æ‡§∞‡•ç‡§ï‡•á‡§ü ‡§Æ‡•á‡§Ç ‡§â‡§§‡§æ‡§∞‡•Ä #RTPCR  ‡§ï‡§ø‡§ü ViraGen, 98.6% ‡§¶‡•á‡§ó‡•Ä ‡§∞‡§ø‡§ú‡§≤‡•ç‡§ü  #viragen #CiplaCoronaTestingKit   https://t.co/XHJlVUsOI2,#COVID19 : Cipla ‡§®‡•á ‡§≤‡•â‡§®‡•ç‡§ö ‡§ï‡§ø‡§Ø‡§æ ‡§®‡§Ø‡§æ ‡§Ü‡§∞‡§ü‡•Ä-‡§™‡•Ä‡§∏‡•Ä‡§Ü‡§∞ ‡§ü‡•á‡§∏‡•ç‡§ü ‡§ï‡§ø‡§ü, ‡§Ü‡§ú ‡§∏‡•á 'ViraGen' ‡§¨‡§ø‡§ï‡•ç‡§∞‡•Ä ‡§ï‡•á ‡§≤‡§ø‡§è ‡§â‡§™‡§≤‡§¨‡•ç‡§ß #coronatest  https://t.co/YY1svwTyfO,Business it is !  ""Antibody cocktail launched in India at Rs 59,750 per dose.""  #RocheIndia #Cipla #Covid19  https://t.co/Aghhq3IzEr,Cipla‚Äôs real time COVID-19 testing kit to be sold from today   https://t.co/qD5hJvqClU #Coronavirus,Doctors on my timeline, how significant is this?   Roche's Antibody Cocktail Launched in India at Rs 59,750/Dose; Cipla to Market Drug in Country  https://t.co/YtJ2JVR73o,A real-time Covid-19 testing kit, launched last week pharmaceutical major Cipla, will hit the markets today.    https://t.co/YuIV7bVShS,Cipla's COVID-19 real-time test kit 'ViraGen' to be sold from today  https://t.co/8ltHiO8shf,Cipla‚Äôs RT-PCR test kit called ‚ÄòViraGen‚Äô which was launched last week will be available in the market from today. #Viragen #Cipla  #COVIDEmergency #COVIDSecondWave    https://t.co/LrJNG0LKSJ,Covid-19 testing kit: ‡§¨‡§æ‡§ú‡§æ‡§∞ ‡§Æ‡•á‡§Ç ‡§Ü‡§ú ‡§∏‡•á ‡§Æ‡§ø‡§≤‡•á‡§ó‡•Ä Cipla ‡§ï‡•Ä ‡§∞‡§ø‡§Ø‡§≤ ‡§ü‡§æ‡§á‡§Æ ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§ü‡•á‡§∏‡•ç‡§ü‡§ø‡§Ç‡§ó ‡§ï‡§ø‡§ü, ‡§ú‡§æ‡§®‡•á‡§Ç ‡§π‡§∞ ‡§ú‡§æ‡§®‡§ï‡§æ‡§∞‡•Ä  https://t.co/yIovL8aAtd #coronavirus #Covid-19testingkit,Cipla ‡§®‡•á ‡§≤‡•â‡§®‡•ç‡§ö ‡§ï‡§ø‡§Ø‡§æ ‡§®‡§Ø‡§æ RT-PCR ‡§ü‡•á‡§∏‡•ç‡§ü ‡§ï‡§ø‡§ü, ‡§Ü‡§ú ‡§∏‡•á 'Vira-Gen' ‡§¨‡§ø‡§ï‡•ç‡§∞‡•Ä ‡§ï‡•á ‡§≤‡§ø‡§è ‡§â‡§™‡§≤‡§¨‡•ç‡§ß  #Coronapandemic #COVID19    https://t.co/ZKJr58VmXd,Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose   https://t.co/1SyxgBsWOe,Reliance Home, India Cements, Bharti Airtel, Cadila, Cipla, Panacea Biotec, Alembic Pharma stocks in focus #bhartiairtel #StocksInFocus #stocks #nifty50 #StockMarket   https://t.co/oZMliVMBQN,#morning India @MotilalOswalLtd #StocksToWatch  #Cipla launches covid antibody cocktail Strong Q4 nos Balaji Amines, J K Paper, IG Petro #AMARAJABAT block. 1.7 cr shares flr price 746. #Ramco Adverse regional mix leads to weaker margins #MGL EBITDA and vol in line  #Nifty #stocks,#StocksToWatch 1. Cipla: launches COVID treatment drug by Roche  2. Amara Raja: stake sale of 10% at disc of 4.8%  3. Polyplex: strong rslt by its subs in Thailand   4. Navneet Pub: board meet to mull buyback on May 27  5. HDFC Bk: cautious comment on delinquency in retail loans,‡§Ü‡§ú Cipla ‡§î‡§∞ Mahanagar Gas ‡§≠‡§∞ ‡§∏‡§ï‡§§‡•á ‡§π‡•à‡§Ç ‡§®‡§ø‡§µ‡•á‡§∂‡§ï‡•ã‡§Ç ‡§ï‡•Ä ‡§ù‡•ã‡§≤‡•Ä  https://t.co/i5vYYPsQXL via @NavbharatTimes,#Cipla &amp; #Grasim Industries are among the top #stocks to watch out for today. Here's the full list: #StockMarket #StocksToWatch #StocksInNews    https://t.co/YFAHZ59CqI,Cipla's Covid-19 real-time test kit 'ViraGen' to be sold from today  https://t.co/wRn5QXcjwi"
2021-05-26,945.1500244140624,941.0,951.9500122070312,939.0499877929688,5445187.0,"Pharma companies Roche India and Cipla have announced the availability of their antibody cocktail drug to treat patients in India.  It will be used to treat mild to moderate cases in high-risk patients.,‡§Ü‡§ú ‡§¶‡•á‡§∂ ‡§ï‡•Ä ‡§®‡§æ‡§Æ‡•Ä ‡§¶‡§µ‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä #Cipla ‡§ï‡•á ‡§Ö‡§ß‡§ø‡§ï‡§æ‡§∞‡§ø‡§Ø‡•ã‡§Ç ‡§®‡•á ‡§á‡§Ç‡§¶‡•å‡§∞ ‡§™‡•ç‡§∞‡§∂‡§æ‡§∏‡§® ‡§ï‡•ã ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§î‡§∞ ‡§¨‡•ç‡§≤‡•à‡§ï ‡§´‡§Ç‡§ó‡§∏ ‡§∏‡•á ‡§≤‡§°‡§º‡§®‡•á ‡§ï‡•á ‡§≤‡§ø‡§è 50 ‡§≤‡§æ‡§ñ ‡§ï‡•Ä ‡§∞‡§æ‡§∂‡§ø ‡§ï‡•á ‡§ú‡§∞‡•Ç‡§∞‡•Ä ‡§Æ‡•á‡§°‡§ø‡§ï‡§≤ ‡§á‡§ï‡•ç‡§µ‡§ø‡§™‡§Æ‡•á‡§Ç‡§ü‡•ç‡§∏ ‡§∏‡•å‡§Ç‡§™‡•á ‡§π‡•à‡•§ ‡§∏‡§æ‡§• ‡§π‡•Ä ‡§¨‡•ç‡§≤‡•à‡§ï ‡§´‡§Ç‡§ó‡§∏ ‡§Æ‡•á‡§Ç ‡§â‡§™‡§Ø‡•ã‡§ó ‡§Ü ‡§∞‡§π‡•á ‡§á‡§Ç‡§ú‡•á‡§ï‡•ç‡§∂‡§®‡•ç‡§∏ ‡§ï‡•Ä ‡§Ü‡§™‡•Ç‡§∞‡•ç‡§§‡§ø ‡§ï‡§æ ‡§Ü‡§∂‡•ç‡§µ‡§æ‡§∏‡§® ‡§≠‡•Ä ‡§¶‡§ø‡§Ø‡§æ‡•§ #‡§≤‡§°‡§º‡•á‡§Ç‡§ó‡•á_‡§ú‡•Ä‡§§‡•á‡§Ç‡§ó‡•á #IndoreFightsCorona  https://t.co/s0vuSOMZ4X,India Fights Back:  - ISRO to use nuclear energy for deep space missions - Cipla launches 'Viragen' - COVID FAQs with AIIMS Director Dr. Randeep Guleria - and other Good news stories  PBNS Daily Magazine - 26 May 2021 #IndiaFightsBack  Magazine Link:  https://t.co/DGcyQiaUBm  https://t.co/cZ1mSEjZzx,#cii ‡§ï‡§®‡•ç‡§´‡•á‡§°‡§∞‡•á‡§∂‡§® ‡§ë‡§´ ‡§á‡§Ç‡§°‡§ø‡§Ø‡§® ‡§á‡§Ç‡§°‡§∏‡•ç‡§ü‡•ç‡§∞‡•Ä‡§ú ‡§ï‡•á ‡§≤‡•ã‡§ï‡§≤ ‡§ö‡•á‡§™‡•ç‡§ü‡§∞ ‡§î‡§∞ #cipla ‡§®‡•á ‡§Ü‡§ú ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§∏‡•á ‡§≤‡§°‡§º‡§®‡•á ‡§ï‡•á ‡§≤‡§ø‡§è ‡§™‡•ç‡§∞‡§∂‡§æ‡§∏‡§® ‡§ï‡•ã ‡§ï‡•Å‡§õ ‡§â‡§™‡§ï‡§∞‡§£ ‡§î‡§∞ ‡§∏‡§æ‡§Æ‡§ó‡•ç‡§∞‡•Ä ‡§∏‡•å‡§Ç‡§™‡•Ä‡•§ ‡§á‡§∏ ‡§Ö‡§µ‡§∏‡§∞ ‡§™‡§∞ ‡§Æ‡§Ç‡§§‡•ç‡§∞‡•Ä ‡§∂‡•ç‡§∞‡•Ä @tulsi_silawat ‡§ú‡•Ä ‡§î‡§∞ ‡§∏‡§æ‡§Ç‡§∏‡§¶ @iShankarLalwani ‡§ú‡•Ä ‡§≠‡•Ä ‡§â‡§™‡§∏‡•ç‡§•‡§ø‡§§ ‡§•‡•á‡•§  https://t.co/LBpFwGDqJX,@vaibhav83517742 @Vanshik63580465 @Anurag_Senger_ @ProfessorOffice @Cipla_Global @drharshvardhan @CMODelhi @SatyendarJain @MoHFW_INDIA @arunharisharma1 @abscraj @tehseenp @ArvindKejriwal Trying to find Govt hosp for u where it‚Äôs available,It is learnt that Cipla has already evinced interest in procuring 50 million doses from #Moderna for 2022 and has requested confirmation from the central government   https://t.co/g3j4diZmQy,Nifty Pharma gains momentum in trade; Sun Pharma and Cipla lead gains  https://t.co/4LREVKP6g0 #nifty #niftypharma #sensex #StockMarket #StocksToBuy #StocksToWatch #stocks #sunpharma #Cipla,Moderna in talks with Cipla, likely to launch single-dose Covid vaccine in India in 2022  Payal Banerjee @payaljourno and Prashant Rangnekar @prashant85 report   https://t.co/epp9hnBSN5,Watch : Here's all you need to know about the @Roche and @Cipla_Global 's #AntiBody Cocktail   https://t.co/jDVBbmdaih,#Moderna¬†is expecting to launch a¬†single-dose #COVID19 vaccine¬†in India next year &amp; is in talks with @Cipla_Global among other Indian firms.  @moderna_tx   https://t.co/8B6XPI9g3u,Opening Bell: Markets open higher; Nifty above 15,200. Sensex up over 100 pts. Gainers: Cipla, M&amp;M, Titan (+1%). Losers: JSW Steel (-3.26%), Tata Steel, Hindalco (-2%).  https://t.co/g8WjCVZWXC #SENSEX #Nifty #NIFTYMETAL,‡§≠‡§æ‡§∞‡§§ ‡§ï‡•Ä ‡§¶‡§ø‡§ó‡•ç‡§ó‡§ú ‡§´‡§æ‡§∞‡•ç‡§Æ‡§æ ‡§ï‡§Ç‡§™‡§®‡•Ä ‡§∏‡§ø‡§™‡•ç‡§≤‡§æ ‡§®‡•á ‡§∞‡§ø‡§Ø‡§≤ ‡§ü‡§æ‡§á‡§Æ ‡§ï‡•ã‡§µ‡§ø‡§°-19 ‡§ü‡•á‡§∏‡•ç‡§ü ‡§ï‡§ø‡§ü ‡§¨‡§æ‡§ú‡§æ‡§∞ ‡§Æ‡•á‡§Ç ‡§â‡§§‡§æ‡§∞ ‡§¶‡•Ä ‡§π‡•à.   #Cipla #ViraGen #RTPCRKit    https://t.co/qGObrrsGQF,Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla for it.   https://t.co/Gf0dXkXP3M,#morning India @MotilalOswalLtd #StocksToWatch  #Cipla - #Moderna  to launch a single-dose vaccine. Talks with cipla (not exclusive deal) #gold  touches 1900/ounce Muthoot Finüëç #Emami  Sales in line;  margin pressure  #Thermax Rev disappoints in key execution qtr; #Nifty #stocks,Moderna is expecting to launch a single-dose #CovidVaccine in India next year and is in talks with Cipla among other Indian firms.   https://t.co/NS9G7xid7U,Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms  #India #CovidVaccines #VaccinationDrive #Moderna #Pfizer #RE    https://t.co/UBoUBo0HUd,What is Covid antibody cocktail: How does Roche, Cipla drug work and pricing.  Now this!  #COVID19 #Cipla #Roche   https://t.co/h8nkHEDbYG"
2021-05-27,,,,,,Moderna is expecting to launch a single-dose #CovidVaccine in India next year and is in talks with Cipla among other Indian firms.   https://t.co/NS9G7xid7U
